Sr.No.,Schedule Date,Locality,Age,Gender,Modality,Type of Procedure(s) Requested,Type of Test(s) Requested,Test Result(s),Provisional Diagnosis,Principal Diagnosis,Additional Diagnosis,Pregnant Patient,NHIA Patient,Medicine Prescribed,Medicine Dispensed,Occupation,Ward/Room,Date of Admission,Date of Discharge,Outcome of Discharge,Surgical Procedure,Cost of Treatment (GHS ),Admission Type,E-tracking Number
96,30-06-2023,new bortianor,57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, A02.25 [Salmonella pyelonephritis]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ], POTASSIUM CITRATE MIXTURE BP[ MIST POT CIT | 200ML | Mixture | TID |  For 10 Days  ], WARFARIN 5MG[  |  |  | BID |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], POTASSIUM CITRATE MIXTURE BP[ MIST POT CIT | 200ML | Mixture ], WARFARIN 5MG[  |  |  ]",,,30-06-2023,30-06-2023,,,10,OPD,
153,30-06-2023,GBAWE,46 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"M54.4 [Lumbago with sciatica]  ==> OLD, I10.00 [Essential (primary) hypertension]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository ]",,,30-06-2023,30-06-2023,,,10,OPD,
194,30-06-2023,KASOA,70 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,"MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD, E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> NEW",,No,Insured,"INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet | OD |  For 60 Days  ]","INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet ]",,,30-06-2023,30-06-2023,,,50,OPD,
374,30-06-2023,"APLAKU OPP KINGS UNI, BARRIER",41 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,Yes,Insured,,,TRADER,,30-06-2023,30-06-2023,,,10,OPD,
519,30-06-2023,"GALILEA
WEST END SCHOOL",36 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> NEW,,No,Non-Insured,"INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | OD |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | OD |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule | Daily |  For 14 Days  ]","INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule ]",TRADER,,30-06-2023,30-06-2023,,,145,OPD,
582,30-06-2023,MCCARTHY JUNCTION,59 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,"E11.40 [Type 2 diabetes mellitus with diabetic neuropathy, unspecified]  ==> OLD",I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,30-06-2023,30-06-2023,,,0,OPD,30308/17  MR-1B-A6-8
685,29-06-2023,KASOA BLUETOP,55 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD,"R16.0 [Hepatomegaly, not elsewhere classified]  ==> NEW, K56.3 [Gallstone ileus]  ==> NEW",No,Insured,,,,,29-06-2023,29-06-2023,,,20,OPD,
701,29-06-2023,AWOSHIE,59 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> NEW,"N39.0 [Urinary tract infection, site not specified]  ==> NEW",No,Non-Insured,"CEFUROXIME INJECTION 750MG[ CEFUROXIME | 750MG | Injection | Stat |  For 1 Days  ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet | BDS |  For 5 Days  ], IRON(III)POLYMALTOSE COMPLEX SUSPENSION[ IRON (111)POLYMALTOSE COMPLEX  | 200ML | Syrup | BDS |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 15 Days  ]","CEFUROXIME INJECTION 750MG[ CEFUROXIME | 750MG | Injection ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet ], IRON(III)POLYMALTOSE COMPLEX SUSPENSION[ IRON (111)POLYMALTOSE COMPLEX  | 200ML | Syrup ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",TRADER,,29-06-2023,29-06-2023,,,60,OPD,
781,29-06-2023,dankuman,58 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> NEW,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",TRADER,,29-06-2023,29-06-2023,,,20,OPD,
782,29-06-2023,weija,66 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,29-06-2023,29-06-2023,,,20,OPD,
788,29-06-2023,weija,52 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TDS |  For 10 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet ]",,,29-06-2023,29-06-2023,,,10,OPD,
790,29-06-2023,ablekuman ,79 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, K29.1 [Other acute gastritis]  ==> OLD, A01.0 [Typhoid fever]  ==> OLD, F06.4 [Organic anxiety disorder]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], ATENOLOL TABLET 50MG[ ATENOLOL | 50MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TDS |  For 10 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ]",,,,29-06-2023,29-06-2023,,,20,OPD,
792,29-06-2023,KOKROBITE,52 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, K29.1 [Other acute gastritis]  ==> OLD",No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], GILOBA[ GILOBA | 40MG | Capsule | OD |  For 30 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TDS |  For 10 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], GILOBA[ GILOBA | 40MG | Capsule ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ]",Unemployed,,29-06-2023,29-06-2023,,,20,OPD,
796,29-06-2023,"MILE 11 , FINNEY HOSPITAL - WEIJA",64 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,,No,Insured,"TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BDS |  For 5 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ]","TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,29-06-2023,29-06-2023,,,10,OPD,
802,29-06-2023,kasoa,63 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,29-06-2023,29-06-2023,,,20,OPD,
818,29-06-2023,DODI MEMPEASEM AT YAO  HOUSE,79 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, A02.25 [Salmonella pyelonephritis]  ==> OLD, K29.1 [Other acute gastritis]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, E78.5 [Hyperlipidaemia, unspecified]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TDS |  For 10 Days  ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet | BID |  For 5 Days  ], WARFARIN 5MG[  |  |  | OD |  For 90 Days  ], POTASSIUM CITRATE MIXTURE BP[ MIST POT CIT | 200ML | Mixture | TID |  For 5 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet ], WARFARIN 5MG[  |  |  ], POTASSIUM CITRATE MIXTURE BP[ MIST POT CIT | 200ML | Mixture ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",,,29-06-2023,29-06-2023,,,25,OPD,
907,29-06-2023,new weija,59 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"H40.59 [Ocular hypertension, unspecified eye]  ==> NEW",No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,29-06-2023,29-06-2023,,,10,OPD,
944,29-06-2023,Dansoman,57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, F06.4 [Organic anxiety disorder]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ]",,,29-06-2023,29-06-2023,,,20,OPD,
955,29-06-2023,ACCRA,59 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, M10.09 [Idiopathic gout, multiple sites]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, D63.1 [Anemia in chronic kidney disease]  ==> OLD",No,Insured,,,civil servant,,29-06-2023,29-06-2023,,,10,OPD,
968,29-06-2023,ODORKOR OFF TOWN,73 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, B50.9 [Plasmodium falciparum malaria, unspecified]  ==> OLD, F51.02 [Adjustment insomnia]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], ARTEMETHER+LUMEFANTRIN 80/480MG(LONART)[  | 80mg/480mg | Tablet | BID |  For 3 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], ARTEMETHER+LUMEFANTRIN 80/480MG(LONART)[  | 80mg/480mg | Tablet ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ]",,,29-06-2023,29-06-2023,,,20,OPD,
970,29-06-2023,mccarthy,57 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | BID |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], WARFARIN 5MG[  |  |  ]",,,29-06-2023,29-06-2023,,,10,OPD,
971,29-06-2023,AWOSHIE,48 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD, D34.00 [Benign neoplasm of thyroid gland]  ==> OLD, F06.4 [Organic anxiety disorder]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TDS |  For 10 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ], WARFARIN 5MG[  |  |  | OD |  For 30 Days  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], WARFARIN 5MG[  |  |  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ]",,,29-06-2023,29-06-2023,,,20,OPD,
983,29-06-2023,GBAWE,81 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I27.0 [Primary pulmonary hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], WARFARIN 5MG[  |  |  | BID |  For 30 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], WARFARIN 5MG[  |  |  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,29-06-2023,29-06-2023,,,10,OPD,
1008,29-06-2023,bortianor,50 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,29-06-2023,29-06-2023,,,20,OPD,
1010,29-06-2023,gbawe,57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, F06.4 [Organic anxiety disorder]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ]",,,29-06-2023,29-06-2023,,,10,OPD,
1011,29-06-2023,weija,75 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,29-06-2023,29-06-2023,,,20,OPD,
1094,29-06-2023,ABLEKUMAH OLEBU,51 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD,,No,Non-Insured,,,TRADER,,29-06-2023,29-06-2023,,,50,OPD,
1331,29-06-2023,MALLAM,55 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> NEW,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], METOCLOPRAMIDE INJECTION 10MG[ METOCLOPRAMIDE | 10MG/2ML | Injection | Stat |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], METOCLOPRAMIDE INJECTION 10MG[ METOCLOPRAMIDE | 10MG/2ML | Injection ]",TRADER,,29-06-2023,29-06-2023,,,85,OPD,
1456,28-06-2023,KASOA-ADADE,83 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E13.42 [Other specified diabetes mellitus with diabetic polyneuropathy]  ==> RECURRING,,No,Insured,PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | BDS |  For 30 Days  ],,,,28-06-2023,28-06-2023,,,10,OPD,
1647,27-06-2023,TUBA SCHOOL JUNCION,51 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,"E08.3219 [Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye]  ==> NEW",I10.00 [Essential (primary) hypertension]  ==> NEW,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | OD |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | OD |  For 1 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 15 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | Daily |  For 30 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ]",,,27-06-2023,27-06-2023,,,145,OPD,
1680,27-06-2023,"AMANFRO
GALILEA",57 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD,,No,Non-Insured,,,,,27-06-2023,27-06-2023,,,60,OPD,
1703,27-06-2023,KASOA-OLD BORTIANOR,60 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, F20.3 [Undifferentiated schizophrenia]  ==> OLD",No,Insured,,,,,27-06-2023,27-06-2023,,,25,OPD,
1706,27-06-2023,kasoa,62 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,27-06-2023,27-06-2023,,,30,OPD,
1707,27-06-2023,SCC,61 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD,,No,Non-Insured,,,TRADER,,27-06-2023,27-06-2023,,,50,OPD,
1714,27-06-2023,"KASOA
KAKRABA",56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, F06.4 [Organic anxiety disorder]  ==> OLD, I10.00 [Essential (primary) hypertension]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ]",,,27-06-2023,27-06-2023,,,20,OPD,
1724,27-06-2023,MALLAM ,55 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, D46.4 [Refractory anaemia, unspecified]  ==> OLD, K25.3 [Gastric ulcer: Acute without haemorrhage or perforation]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TDS |  For 10 Days  ], FERROUS GLUCONATE  SYRUP[ TOT-HEMA (IN AMPOULES) | 10ML | Syrup | BID |  For 14 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], FERROUS GLUCONATE  SYRUP[ TOT-HEMA (IN AMPOULES) | 10ML | Syrup ]",,,27-06-2023,27-06-2023,,,10,OPD,
1726,27-06-2023,santa maria,63 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TID |  For 10 Days  ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule | BID |  For 10 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ]",,,,27-06-2023,27-06-2023,,,20,OPD,
1764,27-06-2023,mccarthy ,66 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,27-06-2023,27-06-2023,,,20,OPD,
1772,27-06-2023,kasoa,69 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,27-06-2023,27-06-2023,,,20,OPD,
1854,27-06-2023,KASOA ,59 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,27-06-2023,27-06-2023,,,20,OPD,
1859,27-06-2023,ablekuman,66 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, F06.4 [Organic anxiety disorder]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | BID |  For 90 Days  ], AMITRIPTYLINE TABLET 50MG[ AMITRIPTYLINE | 50MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], AMITRIPTYLINE TABLET 50MG[ AMITRIPTYLINE | 50MG | Tablet ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,27-06-2023,27-06-2023,,,20,OPD,
1862,27-06-2023,gbawe zero,72 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TDS |  For 10 Days  ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule | BID |  For 10 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ], WARFARIN 5MG[  |  |  | BID |  For 90 Days  ]",,,,27-06-2023,27-06-2023,,,10,OPD,
1873,27-06-2023,BODOMASI,46 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], CELECOXIB[ CELEBREX | 200MG |  | BDS |  For 7 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], CELECOXIB[ CELEBREX | 200MG |  ]",,,27-06-2023,27-06-2023,,,20,OPD,
1893,27-06-2023,SOWUTUOM,66 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD, M54.4 [Lumbago with sciatica]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository | BID |  For 5 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",none,,27-06-2023,27-06-2023,,,10,OPD,
1968,27-06-2023,KASOA AKWELEY,61 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",TRADER,,27-06-2023,27-06-2023,,,20,OPD,
1994,27-06-2023,ABLEKUMA NIC,61 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, F51.02 [Adjustment insomnia]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ]",,,27-06-2023,27-06-2023,,,20,OPD,17115546
1996,27-06-2023,kasao,58 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I16.0 [Hypertensive urgency]  ==> OLD, R00.0 [Tachycardia, unspecified]  ==> OLD",No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Nocte |  For 30 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,27-06-2023,27-06-2023,,,20,OPD,
2061,27-06-2023,Ofankor,53 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,27-06-2023,27-06-2023,,,10,OPD,
2109,27-06-2023,"KWASHIEMAN , HAPPY KIDS ",41 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, M10.09 [Idiopathic gout, multiple sites]  ==> OLD, A20.7 [Septicaemic plague]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BID |  For 7 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]",,,,27-06-2023,27-06-2023,,,10,OPD,
2191,27-06-2023,"MALLAM , MASALACHI ",69 Year(s),Male,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | Daily |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ]","NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",,,27-06-2023,27-06-2023,,,0,OPD,
2254,27-06-2023,ABLEKUMA JOMA,50 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,"INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]","INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ]",TRADER,,27-06-2023,27-06-2023,,,145,OPD,
2383,26-06-2023,BLOCK FACTORY OLD SOLDIER LINE,63 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, F52.21 [Male erectile disorder]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]",,,,26-06-2023,26-06-2023,,,20,OPD,
2386,26-06-2023,"McCARTHY HILL, 4, 9TH AVENUE",65 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.21 [Diabetes mellitus due to underlying condition with diabetic nephropathy]  ==> NEW,,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 0 Days  ], RIVAROXABAN[  | 15MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], RIVAROXABAN[  | 15MG | Tablet ]",,,26-06-2023,26-06-2023,,,60,OPD,
2394,26-06-2023,kasoa,67 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], GILOBA[ GILOBA | 40MG | Capsule | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], GILOBA[ GILOBA | 40MG | Capsule ]",,,26-06-2023,26-06-2023,,,10,OPD,
2400,26-06-2023,BORTIANO,58 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.22 [Diabetes mellitus due to underlying condition with diabetic chronic kidney disease]  ==> NEW,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BID |  For 5 Days  ], ASCORBIC ACID TABLET 1G[ (VITAMIN C) | 1000MG | Tablet | TDS |  For 5 Days  ]",,,,26-06-2023,26-06-2023,,,10,OPD,
2417,26-06-2023,AMANFRO,58 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, M54.4 [Lumbago with sciatica]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TID |  For 10 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], WARFARIN 5MG[  |  |  | BID |  For 90 Days  ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], WARFARIN 5MG[  |  |  ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository ]",TRADER,,26-06-2023,26-06-2023,,,20,OPD,
2429,26-06-2023,upper weija,63 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, I20.0 [Unstable angina]  ==> OLD, I30.8 [Other forms of acute pericarditis]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | BID |  For 90 Days  ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BID |  For 7 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], WARFARIN 5MG[  |  |  ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,26-06-2023,26-06-2023,,,10,OPD,
2442,26-06-2023,scc red top ,54 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,26-06-2023,26-06-2023,,,10,OPD,
2456,26-06-2023,upper weija,78 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",,,26-06-2023,26-06-2023,,,20,OPD,
2458,26-06-2023,weija,70 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,26-06-2023,26-06-2023,,,20,OPD,
2459,26-06-2023,amanfo,33 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,26-06-2023,26-06-2023,,,10,OPD,
2475,26-06-2023,kasoa,75 Year(s),Male,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 30 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ]",,,26-06-2023,26-06-2023,,,0,OPD,
2477,26-06-2023,"TUBA
MOUNTAIN VIEW",40 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,26-06-2023,26-06-2023,,,20,OPD,
2534,26-06-2023,mallam station,60 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ]",,,,26-06-2023,26-06-2023,,,20,OPD,
2536,26-06-2023,"BORTIANOR
BROADCASTING",48 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, B37.3 [Candidiasis of vulva and vagina]  ==> OLD",No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TID |  For 10 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet | BID |  For 5 Days  ], FLUCONAZOLE CAPSULE 150MG[ FLUCONAZOLE | 150MG | Capsule | OD |  For 1 Days  ], CLOTRIMAZOLE  PESSARY 200MG[ CLOTRIMAZOLE | 200MG | Tablet | Nocte |  For 6 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet ], FLUCONAZOLE CAPSULE 150MG[ FLUCONAZOLE | 150MG | Capsule ], CLOTRIMAZOLE  PESSARY 200MG[ CLOTRIMAZOLE | 200MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",TRADER,,26-06-2023,26-06-2023,,,20,OPD,
2539,26-06-2023,WEIJA-SCH JUNCTION,56 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,26-06-2023,26-06-2023,,,20,OPD,
2550,26-06-2023,kasoa galileya,58 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TDS |  For 10 Days  ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule | BDS |  For 10 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ]",,,26-06-2023,26-06-2023,,,70,OPD,
2832,26-06-2023,NYAMEKYE NEAR MAB HOSPITAL,65 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | q24h |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ]",,,26-06-2023,26-06-2023,,,10,OPD,
2851,26-06-2023,NYAMEKYE NEAR MAB HOSPITAL,66 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | q24h |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ]",,,26-06-2023,26-06-2023,,,10,OPD,
2971,26-06-2023,WEIJA,60 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet | Nocte |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ]","ATORVASTATIN TABLET 10MG[ ATORVASTATIN | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,26-06-2023,26-06-2023,,,0,OPD,
3056,26-06-2023,KOKROBITE,78 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | Daily |  For 2 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ]",Unemployed,,26-06-2023,26-06-2023,,,85,OPD,
3065,26-06-2023,MALLAM,29 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E13.649 [Other specified diabetes mellitus with hypoglycemia without coma]  ==> NEW,,No,Non-Insured,"DEXTROSE IN SODIUM CHLORIDE INFUSION 5%+0.9%[ DEXTROSE SALINE | 5%+0.9% 500ML | Infusion | Daily |  For 1 Days  ], RINGER'S LACTATE SOLUTION[ RINGERS | 500ML | Infusion | Daily |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]","DEXTROSE IN SODIUM CHLORIDE INFUSION 5%+0.9%[ DEXTROSE SALINE | 5%+0.9% 500ML | Infusion ], RINGER'S LACTATE SOLUTION[ RINGERS | 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ]",,,26-06-2023,26-06-2023,,,95,OPD,
3141,25-06-2023,ODORKOR,63 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.311 [Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy with macular edema]  ==> NEW,,No,Insured,ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Daily |  For 30 Days  ],ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ],Unemployed,,25-06-2023,25-06-2023,,,10,OPD,
3265,24-06-2023,SCC  -AZUMA  DAM  SIDE,76 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Child,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,"PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | Daily |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | OD |  For 1 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 1 Days  ]","PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ]",Pensioner,,24-06-2023,24-06-2023,,,125,OPD,
3406,23-06-2023,MALLAM-JUNCTION,68 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Child,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,"I15.8 [Other secondary hypertension]  ==> NEW, B50.8 [Other severe and complicated Plasmodium falciparum malaria]  ==> NEW, A02.0 [Salmonella enteritis]  ==> NEW",No,Non-Insured,"INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | PRN |  For 1 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], ARTESUNATE INJECTION 120MG[ ARTESUNATE | 120MG | Injection | TID |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ]","INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ARTESUNATE INJECTION 120MG[ ARTESUNATE | 120MG | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ]",Pensioner,,23-06-2023,23-06-2023,,,140,OPD,
3448,23-06-2023,weija,78 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,23-06-2023,23-06-2023,,,20,OPD,
3579,23-06-2023,Scc,74 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 1 Days  ]",,,,23-06-2023,23-06-2023,,,10,OPD,
3651,23-06-2023,WEIJA,79 Year(s),Male,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E11.69 [Type 2 diabetes mellitus with other specified complication]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 30 Days  ], WARFARIN 5MG[  |  |  | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ], WARFARIN 5MG[  |  |  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,23-06-2023,23-06-2023,,,0,OPD,
3862,23-06-2023,ODORKOR NEAR THE POST OFFICE ,29 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E10.1 [Insulin-dependent diabetes mellitus: With ketoacidosis]  ==> NEW,,Yes,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ]",,,23-06-2023,23-06-2023,,,65,OPD,
3877,23-06-2023,ABLEKUMA-CP,32 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.10 [Type 2 diabetes mellitus with ketoacidosis without coma]  ==> NEW,,No,Non-Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | OD |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], AMOXICILIN+CLAVULANIC ACID INJECTION 1.2G[ AMOKSICLAV | 1.2G | Injection | Stat |  For 1 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ], AMOXICILIN+CLAVULANIC ACID INJECTION 1.2G[ AMOKSICLAV | 1.2G | Injection ]",TRADER,,23-06-2023,23-06-2023,,,490,OPD,
3971,22-06-2023,WEIJA   ROMAN,47 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> NEW,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,22-06-2023,22-06-2023,,,20,OPD,
3977,22-06-2023,awoshie,73 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,22-06-2023,22-06-2023,,,10,OPD,
3979,22-06-2023,"TOPBASE
GBAWE",66 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, F06.4 [Organic anxiety disorder]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TDS |  For 10 Days  ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule | BID |  For 10 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet | BID |  For 5 Days  ], WARFARIN 5MG[  |  |  | OD |  For 90 Days  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet ], WARFARIN 5MG[  |  |  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ]",pension,,22-06-2023,22-06-2023,,,25,OPD,
3980,22-06-2023,oblogo,72 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,22-06-2023,22-06-2023,,,10,OPD,
3984,22-06-2023,"DARKUMAN , NEAR AFROPA HOUSE ",52 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD, R00.0 [Tachycardia, unspecified]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TID |  For 10 Days  ],  TABLET SECNIDAZOLE 1G[ SECNIDAZOLE | 1G | Tablet | OD |  For 1 Days  ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BID |  For 7 Days  ], FEXOFENADINE TABLET 120MG (ZYFEN)[ ZYFEN | 120MG | Tablet | OD |  For 10 Days  ]",,,,22-06-2023,22-06-2023,,,70,OPD,
3993,22-06-2023,ablekuman,69 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD, E78.5 [Hyperlipidaemia, unspecified]  ==> OLD",No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | BID |  For 30 Days  ], WARFARIN 5MG[  |  |  | BID |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 30 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], WARFARIN 5MG[  |  |  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",,,22-06-2023,22-06-2023,,,20,OPD,
4003,22-06-2023,GALILEA,52 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, E78.5 [Hyperlipidaemia, unspecified]  ==> OLD, D57.3 [Sickle-cell trait]  ==> OLD",No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ], FOLIC ACID TABLET 5MG[ FOLIC ACID | 5MG | Tablet | OD |  For 90 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], FOLIC ACID TABLET 5MG[ FOLIC ACID | 5MG | Tablet ]",,,22-06-2023,22-06-2023,,,20,OPD,
4005,22-06-2023,WEJIA,66 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, E78.5 [Hyperlipidaemia, unspecified]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,,,,,22-06-2023,22-06-2023,,,20,OPD,
4007,22-06-2023,ASOFA,42 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TID |  For 10 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet | BID |  For 5 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,22-06-2023,22-06-2023,,,20,OPD,
4009,22-06-2023,kasoa,80 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"B35.4 [Tinea corporis]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD, K85.01 [Idiopathic acute pancreatitis with uninfected necrosis]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TDS |  For 10 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], GRISEOFULVIN TABLET 500MG[ GRISEOVULFIN | 500MG | Tablet | BID |  For 14 Days  ],  TABLET SECNIDAZOLE 1G[ SECNIDAZOLE | 1G | Tablet | OD |  For 1 Days  ], BETAMETHASONE DIPROPIONATE LOTION[ DIPROSON  | 0.05% 30G | Lotion | BID |  For 10 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], GRISEOFULVIN TABLET 500MG[ GRISEOVULFIN | 500MG | Tablet ],  TABLET SECNIDAZOLE 1G[ SECNIDAZOLE | 1G | Tablet ], BETAMETHASONE DIPROPIONATE LOTION[ DIPROSON  | 0.05% 30G | Lotion ]",,,22-06-2023,22-06-2023,,,20,OPD,
4010,22-06-2023,benjeys mccarthy,59 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, A20.7 [Septicaemic plague]  ==> OLD, E78.5 [Hyperlipidaemia, unspecified]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, M54.4 [Lumbago with sciatica]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | OD |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository | BID |  For 5 Days  ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BID |  For 7 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], WARFARIN 5MG[  |  |  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ]",Unemployed,,22-06-2023,22-06-2023,,,10,OPD,
4014,22-06-2023,OBLOGO TOP BASE,54 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, M54.4 [Lumbago with sciatica]  ==> NEW",No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | BID |  For 90 Days  ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], WARFARIN 5MG[  |  |  ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository ]",,,22-06-2023,22-06-2023,,,70,OPD,
4063,22-06-2023,ABLEKUMAN,68 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.319 [Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy without macular edema]  ==> OLD,,No,Insured,"TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BDS |  For 5 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 7 Days  ]","TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,22-06-2023,22-06-2023,,,10,OPD,
4087,22-06-2023,GBAWE ZERO,57 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> NEW,I10.00 [Essential (primary) hypertension]  ==> NEW,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | Daily |  For 5 Days  ], MULTIVITAMIN+MINERALS[ EZOTOL |  | Capsule | Daily |  For 30 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ], MULTIVITAMIN+MINERALS[ EZOTOL |  | Capsule ]",,,22-06-2023,22-06-2023,,,60,OPD,
4092,22-06-2023,MACARTHEY HILL,57 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.311 [Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy with macular edema]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 0 Days  ]",,,,22-06-2023,22-06-2023,,,20,OPD,
4100,22-06-2023,SOWUTEOM OMANDJOR,64 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 60 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 60 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 60 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 60 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TID |  For 10 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 60 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",,,22-06-2023,22-06-2023,,,20,OPD,
4102,22-06-2023,kasao,48 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD",No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TDS |  For 10 Days  ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet ]",,,22-06-2023,22-06-2023,,,20,OPD,
4103,22-06-2023,MILE 11. FINI HOSPITAL,62 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | BID |  For 90 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], WARFARIN 5MG[  |  |  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository ]",,,22-06-2023,22-06-2023,,,20,OPD,
4106,22-06-2023,KASOA AKWELEY,73 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"B35.4 [Tinea corporis]  ==> OLD, I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, B35.0 [Tinea barbae and tinea capitis]  ==> OLD",No,Insured,"NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | BID |  For 90 Days  ], GRISEOFULVIN TABLET 500MG[ GRISEOVULFIN | 500MG | Tablet | BID |  For 14 Days  ],  TABLET SECNIDAZOLE 1G[ SECNIDAZOLE | 1G | Tablet | OD |  For 1 Days  ], FEXOFENADINE TABLET 120MG (ZYFEN)[ ZYFEN | 120MG | Tablet | OD |  For 10 Days  ], BETAMETHASONE DIPROPIONATE LOTION[ DIPROSON  | 0.05% 30G | Lotion | BID |  For 10 Days  ], KETOCONAZOLE SHAMPOO[ KETOCONAZOLE SHAMPOO | 2% | Lotion | BID |  For 10 Days  ], ALBENDAZOLE TABLET 400MG[ ALBENDAZOLE | 400MG | Tablet | OD |  For 1 Days  ]","NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], WARFARIN 5MG[  |  |  ], GRISEOFULVIN TABLET 500MG[ GRISEOVULFIN | 500MG | Tablet ],  TABLET SECNIDAZOLE 1G[ SECNIDAZOLE | 1G | Tablet ], FEXOFENADINE TABLET 120MG (ZYFEN)[ ZYFEN | 120MG | Tablet ], BETAMETHASONE DIPROPIONATE LOTION[ DIPROSON  | 0.05% 30G | Lotion ], KETOCONAZOLE SHAMPOO[ KETOCONAZOLE SHAMPOO | 2% | Lotion ], ALBENDAZOLE TABLET 400MG[ ALBENDAZOLE | 400MG | Tablet ]",,,22-06-2023,22-06-2023,,,25,OPD,
4176,22-06-2023,mallam,77 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ]",,,22-06-2023,22-06-2023,,,0,OPD,
4181,22-06-2023,"gbawe
",71 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,22-06-2023,22-06-2023,,,20,OPD,
4183,22-06-2023,weija,58 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,22-06-2023,22-06-2023,,,20,OPD,
4184,22-06-2023,kasoa,58 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> NEW, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | BID |  For 90 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 90 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], WARFARIN 5MG[  |  |  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ]",,,22-06-2023,22-06-2023,,,20,OPD,
4225,22-06-2023,KALABULE ,63 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]",,,,22-06-2023,22-06-2023,,,155,OPD,
4309,22-06-2023,ODORKOR WATER WORKS OPP KPOGAS,66 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD,,No,Insured,,,,,22-06-2023,22-06-2023,,,20,OPD,
4359,22-06-2023,ABLEKUMAN,68 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD,,No,Insured,,,,,22-06-2023,22-06-2023,,,50,OPD,
4399,22-06-2023,"ABLEKUMA
FANMILK",55 Year(s),Male,DIETERAPY,General Consultation Adult,,No Outcome,NA ,MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD,,No,Insured,,,,,22-06-2023,22-06-2023,,,60,OPD,
4519,21-06-2023,camara,36 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,21-06-2023,21-06-2023,,,20,OPD,
4576,21-06-2023,OFANKOR,76 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, M10.09 [Idiopathic gout, multiple sites]  ==> OLD, K85.02 [Idiopathic acute pancreatitis with infected necrosis]  ==> OLD, A01.0 [Typhoid fever]  ==> OLD, D63.1 [Anemia in chronic kidney disease]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], LISINOPRIL TABLET 20MG[ LISINOPRIL | 20MG | Tablet | OD |  For 30 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], WARFARIN 5MG[  |  |  | BID |  For 30 Days  ], IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LISINOPRIL TABLET 20MG[ LISINOPRIL | 20MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], WARFARIN 5MG[  |  |  ], IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule ]",,,21-06-2023,21-06-2023,,,20,OPD,
4594,21-06-2023,mallam,63 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"M10.09 [Idiopathic gout, multiple sites]  ==> OLD, I10.00 [Essential (primary) hypertension]  ==> OLD, K85.02 [Idiopathic acute pancreatitis with infected necrosis]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,,,,,21-06-2023,21-06-2023,,,10,OPD,
4763,21-06-2023,kokorbitey,53 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, B50.9 [Plasmodium falciparum malaria, unspecified]  ==> OLD, F06.4 [Organic anxiety disorder]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], ARTEMETHER+LUMEFANTRIN 80/480MG(LONART)[  | 80mg/480mg | Tablet | BID |  For 3 Days  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], ARTEMETHER+LUMEFANTRIN 80/480MG(LONART)[  | 80mg/480mg | Tablet ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ]",TRADER,,21-06-2023,21-06-2023,,,20,OPD,
4774,21-06-2023,ABLEKUMA,61 Year(s),Female,SURGICAL OPD,Surgical Consultation ,,No Outcome,NA ,E08.52 [Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy with gangrene]  ==> OLD,,No,Insured,"FLUCLOXACILLIN CAPSULE 250MG[ FLUCLOXACILLIN | 250MG | Capsule | QID |  For 7 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | OD |  For 15 Days  ]","FLUCLOXACILLIN CAPSULE 250MG[ FLUCLOXACILLIN | 250MG | Capsule ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ]",,,21-06-2023,21-06-2023,,,20,OPD,
4775,21-06-2023,tuba,53 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ]","GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ]",,,21-06-2023,21-06-2023,,,0,OPD,
4825,21-06-2023,new weija azumah,65 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,21-06-2023,21-06-2023,,,20,OPD,
4976,21-06-2023,ODORKOR,61 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.29 [Diabetes mellitus due to underlying condition with other diabetic kidney complication]  ==> NEW,,No,Non-Insured,,,,,21-06-2023,21-06-2023,,,10,OPD,
5071,21-06-2023,weija ,56 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet | OD |  For 30 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], BENDROFLUAZIDE TABLET 2.5MG[ BENDROFLUAZIDE | 2.5MG | Tablet ]",,,21-06-2023,21-06-2023,,,0,OPD,
5128,20-06-2023,galilea,70 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,"MEDI03A [Diabetes - Complicated >=12 Yrs]  ==> OLD, E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD","MEDI32A [Hypertension >=12 Yrs]  ==> OLD, K27.2 [Peptic ulcer, site unspecified: Acute with both haemorrhage and perforation]  ==> NEW, B50.9 [Plasmodium falciparum malaria, unspecified]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TID |  For 10 Days  ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule | BID |  For 10 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ], WARFARIN 5MG[  |  |  | OD |  For 90 Days  ], ARTEMETHER+LUMEFANTRIN 80/480MG(LONART)[  | 80mg/480mg | Tablet | BID |  For 3 Days  ]","OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], WARFARIN 5MG[  |  |  ], ARTEMETHER+LUMEFANTRIN 80/480MG(LONART)[  | 80mg/480mg | Tablet ]",,,20-06-2023,20-06-2023,,,20,OPD,
5135,20-06-2023,ABLEKUMA,77 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.10 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> NEW,"J15.9 [Bacterial pneumonia, unspecified]  ==> NEW",No,Non-Insured,"CARBOCISTEINE SYRUP[ CARBOCISTEINE -ADULT | 5% 250MG/5ML | Syrup | TID |  For 1 Days  ], AMOXICILLIN+CLAVULINIC ACID TABLET 625MG[ AMOKSICLAV | 500MG+125MG | Tablet | BID |  For 7 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","CARBOCISTEINE SYRUP[ CARBOCISTEINE -ADULT | 5% 250MG/5ML | Syrup ], AMOXICILLIN+CLAVULINIC ACID TABLET 625MG[ AMOKSICLAV | 500MG+125MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,20-06-2023,20-06-2023,,,95,OPD,
5182,20-06-2023,WEIJA JUNCTION,57 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,20-06-2023,20-06-2023,,,10,OPD,
5183,20-06-2023,MALLAM,68 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, K29.1 [Other acute gastritis]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TID |  For 10 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ]",,,20-06-2023,20-06-2023,,,20,OPD,
5184,20-06-2023,galileye,71 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD, D46.4 [Refractory anaemia, unspecified]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | BID |  For 90 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TDS |  For 10 Days  ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule | BID |  For 10 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule | OD |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], WARFARIN 5MG[  |  |  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,20-06-2023,20-06-2023,,,20,OPD,
5187,20-06-2023,ablekuman,62 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,20-06-2023,20-06-2023,,,20,OPD,
5197,20-06-2023,MALLAM,57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,20-06-2023,20-06-2023,,,20,OPD,
5205,20-06-2023,"ABEKA
MANSTE",75 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, I20.0 [Unstable angina]  ==> OLD, I30.9 [Acute pericarditis, unspecified]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BID |  For 7 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], WARFARIN 5MG[  |  |  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ]",,,20-06-2023,20-06-2023,,,20,OPD,
5208,20-06-2023,Broadcasing ,60 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,20-06-2023,20-06-2023,,,10,OPD,
5221,20-06-2023,AWOSHIE - MARKET,72 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, F06.4 [Organic anxiety disorder]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ], AMITRIPTYLINE TABLET 50MG[ AMITRIPTYLINE | 50MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], AMITRIPTYLINE TABLET 50MG[ AMITRIPTYLINE | 50MG | Tablet ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ]",,,20-06-2023,20-06-2023,,,20,OPD,
5226,20-06-2023,ABLEKUMAH-OLEBU,67 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | BID |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], WARFARIN 5MG[  |  |  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,20-06-2023,20-06-2023,,,10,OPD,7640/19
5238,20-06-2023,malla,60 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"A02.25 [Salmonella pyelonephritis]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], POTASSIUM CITRATE MIXTURE BP[ MIST POT CIT | 200ML | Mixture | BID |  For 10 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], POTASSIUM CITRATE MIXTURE BP[ MIST POT CIT | 200ML | Mixture ]",,,20-06-2023,20-06-2023,,,20,OPD,
5242,20-06-2023,AWOSHIE ,49 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,"B50.9 [Plasmodium falciparum malaria, unspecified]  ==> NEW, M43.0 [Spondylolysis]  ==> NEW",No,Insured,"DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule | BDS |  For 5 Days  ], METHYLCOBALAMIN+ALPHA LIPOIC ACID+INOSITOL+FOLIC ACID+CHROMIUM+SELENOMETHIONINE+ZINC[ REZEN |  | Capsule | Daily |  For 30 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BDS |  For 14 Days  ]","DICLOFENAC CAPSULE 75MG[ DICLOFENAC | 75MG | Capsule ], METHYLCOBALAMIN+ALPHA LIPOIC ACID+INOSITOL+FOLIC ACID+CHROMIUM+SELENOMETHIONINE+ZINC[ REZEN |  | Capsule ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,20-06-2023,20-06-2023,,,10,OPD,
5251,20-06-2023,MALLAM KOKROKO,58 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, I64.00 [Stroke, not specified as haemorrhage or infarction]  ==> OLD, F06.4 [Organic anxiety disorder]  ==> NEW",No,Insured,"GILOBA[ GILOBA | 40MG | Capsule | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]","GILOBA[ GILOBA | 40MG | Capsule ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ]",,,20-06-2023,20-06-2023,,,20,OPD,
5252,20-06-2023,"ABLEKUMA
PENTECOST JUNCTION",44 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",driver,,20-06-2023,20-06-2023,,,20,OPD,
5273,20-06-2023,MALLAM MARKET,71 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, E08.40 [Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,20-06-2023,20-06-2023,,,20,OPD,
5281,20-06-2023,agape,64 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, F06.4 [Organic anxiety disorder]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ]",,,20-06-2023,20-06-2023,,,10,OPD,
5298,20-06-2023,AMASAMAN,50 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"K85.02 [Idiopathic acute pancreatitis with infected necrosis]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD, A50.09 [Other early congenital syphilis, symptomatic]  ==> OLD, A01.0 [Typhoid fever]  ==> OLD",No,Insured,"BENZATHINE PENICILIN INJECTION 2.4MU[ BENZATHINE PENICILIN | 2.4MU | Injection | OD |  For 1 Days  ], DOXYCYCLINE CAPSULE 100MG[ DOXYCYCLINE | 100MG | Capsule | BID |  For 14 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TDS |  For 10 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], POTASSIUM CITRATE MIXTURE BP[ MIST POT CIT | 200ML | Mixture | TID |  For 10 Days  ], IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule | OD |  For 30 Days  ]",,,,20-06-2023,20-06-2023,,,75,OPD,
5314,20-06-2023,DARKUMAH,48 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD,,No,Insured,,,,,20-06-2023,20-06-2023,,,20,OPD,
5332,20-06-2023,"OBLOGO, WAREHOUSE",63 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],,,20-06-2023,20-06-2023,,,20,OPD,
5411,20-06-2023,GBAWE  -GONSE,68 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,MEDI03A [Diabetes - Complicated >=12 Yrs]  ==> OLD,,No,Insured,,,,,20-06-2023,20-06-2023,,,20,OPD,
5463,20-06-2023,DARKUMAH,48 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,20-06-2023,20-06-2023,,,75,OPD,
5467,20-06-2023,"NEW GBAWE , TIME SPOT",53 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | BID |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,20-06-2023,20-06-2023,,,20,OPD,
5488,20-06-2023,SANTA MARIA ,68 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> NEW,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,20-06-2023,20-06-2023,,,20,OPD,
5507,20-06-2023,MALLAM,75 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,20-06-2023,20-06-2023,,,25,OPD,
5518,20-06-2023,TUBA,83 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, N41.1 [Chronic prostatitis]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",,,20-06-2023,20-06-2023,,,20,OPD,
5525,20-06-2023,b ortianor,21 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 90 Days  ]",,,,20-06-2023,20-06-2023,,,10,OPD,
5553,20-06-2023,ABLEKUMA-AGAPE,47 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.21 [Type 2 diabetes mellitus with diabetic nephropathy]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | Daily |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",TRADER,,20-06-2023,20-06-2023,,,20,OPD,
5823,19-06-2023,GBAWE,68 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.8 [Type 2 diabetes mellitus with unspecified complications]  ==> NEW,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],Pensioner,,19-06-2023,19-06-2023,,,20,OPD,
5857,19-06-2023,gbawe top base,67 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD, E78.5 [Hyperlipidaemia, unspecified]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TDS |  For 10 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",,,19-06-2023,19-06-2023,,,10,OPD,
5858,19-06-2023,mallam,60 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, M79.1 [Myalgia]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,19-06-2023,19-06-2023,,,20,OPD,
5859,19-06-2023,weija,43 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",,,19-06-2023,19-06-2023,,,20,OPD,
5866,19-06-2023,SCC,62 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,19-06-2023,19-06-2023,,,10,OPD,
5867,19-06-2023,ABLEKUMA PENTECOST JUNCTION,74 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, F06.4 [Organic anxiety disorder]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ]",,,19-06-2023,19-06-2023,,,20,OPD,
5875,19-06-2023,awoshie,60 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,19-06-2023,19-06-2023,,,20,OPD,
5884,19-06-2023,kasoa,59 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, R00.0 [Tachycardia, unspecified]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], ATENOLOL TABLET 50MG[ ATENOLOL | 50MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ATENOLOL TABLET 50MG[ ATENOLOL | 50MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,19-06-2023,19-06-2023,,,20,OPD,
5888,19-06-2023,tetegu,53 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, F06.4 [Organic anxiety disorder]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ]",,,19-06-2023,19-06-2023,,,20,OPD,
5894,19-06-2023,TETEGU,49 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,19-06-2023,19-06-2023,,,20,OPD,
5898,19-06-2023,kasoa,64 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,19-06-2023,19-06-2023,,,10,OPD,
5913,19-06-2023,"ablekuman
fan milk",57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,19-06-2023,19-06-2023,,,10,OPD,
5920,19-06-2023,"ANYAA , MARKET ",64 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"E78.5 [Hyperlipidaemia, unspecified]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",,,19-06-2023,19-06-2023,,,15,OPD,
5993,19-06-2023,SANTA MARIA,65 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",,,19-06-2023,19-06-2023,,,20,OPD,
5994,19-06-2023,manprobi,59 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, I20.9 [Angina pectoris, unspecified]  ==> OLD, F06.4 [Organic anxiety disorder]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD",No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TDS |  For 10 Days  ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BID |  For 7 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | T","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ]",,,19-06-2023,19-06-2023,,,10,OPD,
5997,19-06-2023,kasoa,53 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ]",,,19-06-2023,19-06-2023,,,20,OPD,
5999,19-06-2023,WEIJA-SCH JUNCTION,56 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,19-06-2023,19-06-2023,,,20,OPD,
6069,19-06-2023,Tetegu,71 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"R00.1 [Bradycardia, unspecified]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",TRADER,,19-06-2023,19-06-2023,,,10,OPD,
6167,19-06-2023,"GBAWE , CP",76 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, B35.3 [Tinea pedis]  ==> OLD",No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | BID |  For 90 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 90 Days  ], BETAMETHASONE DIPROPIONATE LOTION[ DIPROSON  | 0.05% 30G | Lotion | BID |  For 10 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], WARFARIN 5MG[  |  |  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ], BETAMETHASONE DIPROPIONATE LOTION[ DIPROSON  | 0.05% 30G | Lotion ]",,,19-06-2023,19-06-2023,,,70,OPD,
6293,19-06-2023,"SANTA MARIA
DRUG STORE",71 Year(s),Male,DIETERAPY,General Consultation Adult,,No Outcome,NA ,PAED02C [Diabetes - Simple <12 Yrs]  ==> NEW,,No,Insured,,,,,19-06-2023,19-06-2023,,,30,OPD,
6775,17-06-2023,"AMANFRO
GALILEA",57 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,B37.3 [Candidiasis of vulva and vagina]  ==> NEW,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | OD |  For 30 Days  ], CLOTRIMAZOLE CREAM,2%[ CLOTRIMAZOLE | 2% 30G | Cream | BDS |  For 7 Days  ], FLUCONAZOLE CAPSULE 150MG[ FLUCONAZOLE | 150MG | Capsule | Stat |  For 1 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], CLOTRIMAZOLE CREAM,2%[ CLOTRIMAZOLE | 2% 30G | Cream ], FLUCONAZOLE CAPSULE 150MG[ FLUCONAZOLE | 150MG | Capsule ]",,,17-06-2023,17-06-2023,,,60,OPD,
6828,17-06-2023,"ODUMAN NEAR CHURCH OFCHRIST
ABLEKUMA",55 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E08.622 [Diabetes mellitus due to underlying condition with other skin ulcer]  ==> NEW,"R73.9 [Hyperglycaemia, unspecified]  ==> NEW",No,Insured,"INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | OD |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | OD |  For 1 Days  ], TRAMADOL INJECTION 100MG[ TRAMADOL | 100MG/2ML | Injection | BDS |  For 1 Days  ], CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection | QID |  For 1 Days  ]","INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], TRAMADOL INJECTION 100MG[ TRAMADOL | 100MG/2ML | Injection ], CLINDAMYCIN INJECTION 300MG[ CLINDAMYCIN  | 150MG/ML IN 2ML | Injection ]",,,17-06-2023,17-06-2023,,,65,OPD,
6932,16-06-2023,"WEIJA -
POLICE STATION ",64 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ]",,,,16-06-2023,16-06-2023,,,0,OPD,
6942,16-06-2023,ablekuman,62 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, D46.4 [Refractory anaemia, unspecified]  ==> OLD, A01.0 [Typhoid fever]  ==> OLD, K29.1 [Other acute gastritis]  ==> OLD",No,Insured,,,,,16-06-2023,16-06-2023,,,20,OPD,
6952,16-06-2023,mallam bola raod,81 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], ATENOLOL TABLET 50MG[ ATENOLOL | 50MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], ATENOLOL TABLET 50MG[ ATENOLOL | 50MG | Tablet ]",,,16-06-2023,16-06-2023,,,20,OPD,
6954,16-06-2023,new apleku,67 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, B37.3 [Candidiasis of vulva and vagina]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], FLUCONAZOLE CAPSULE 150MG[ FLUCONAZOLE | 150MG | Capsule | Nocte |  For 1 Days  ], CLOTRIMAZOLE  PESSARY 200MG[ CLOTRIMAZOLE | 200MG | Tablet | Nocte |  For 6 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], FLUCONAZOLE CAPSULE 150MG[ FLUCONAZOLE | 150MG | Capsule ], CLOTRIMAZOLE  PESSARY 200MG[ CLOTRIMAZOLE | 200MG | Tablet ]",,,16-06-2023,16-06-2023,,,20,OPD,
6974,16-06-2023,awoshie market,55 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",TRADER,,16-06-2023,16-06-2023,,,20,OPD,
7098,16-06-2023,SCC JUNCTION,73 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, B50.9 [Plasmodium falciparum malaria, unspecified]  ==> OLD, F06.4 [Organic anxiety disorder]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | BID |  For 90 Days  ], ARTEMETHER+LUMEFANTRIN 80/480MG(LONART)[  | 80mg/480mg | Tablet | BID |  For 30 Days  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], WARFARIN 5MG[  |  |  ], ARTEMETHER+LUMEFANTRIN 80/480MG(LONART)[  | 80mg/480mg | Tablet ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ]",,,16-06-2023,16-06-2023,,,20,OPD,
7255,16-06-2023,awoshie,86 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ]","GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",,,16-06-2023,16-06-2023,,,0,OPD,
7284,16-06-2023,KWASHIEMAN ZONGO,67 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.69 [Type 2 diabetes mellitus with other specified complication]  ==> NEW,,No,Insured,,,Unemployed,,16-06-2023,16-06-2023,,,10,OPD,
7300,16-06-2023,WEIJA-MANDELA SCC,72 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,16-06-2023,16-06-2023,,,0,OPD,21620/19
7318,16-06-2023,ABLEKUMA OLEBU,59 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> NEW,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ]",Unemployed,,16-06-2023,16-06-2023,,,30,OPD,
7479,15-06-2023,"TUBA , BORTIANOR HILLS",56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TDS |  For 10 Days  ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet | BID |  For 5 Days  ],  TABLET SECNIDAZOLE 1G[ SECNIDAZOLE | 1G | Tablet | OD |  For 1 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet ],  TABLET SECNIDAZOLE 1G[ SECNIDAZOLE | 1G | Tablet ]",ACCOUNTANT,,15-06-2023,15-06-2023,,,20,OPD,
7489,15-06-2023,UPPER WEIJA,66 Year(s),Male,DIETERAPY,General Consultation Adult,,No Outcome,NA ,MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD,,No,Insured,,,pension,,15-06-2023,15-06-2023,,,20,OPD,
7512,15-06-2023,AKWELEY NEW TOWN,52 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,15-06-2023,15-06-2023,,,10,OPD,
7513,15-06-2023,KASOA-LAMPTEY MILLS,60 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, A50.39 [Other late congenital syphilitic oculopathy]  ==> OLD, K27.2 [Peptic ulcer, site unspecified: Acute with both haemorrhage and perforation]  ==> OLD, E78.5 [Hyperlipidaemia, unspecified]  ==> OLD",No,Insured,"FERROUS GLUCONATE  SYRUP[ TOT-HEMA (IN AMPOULES) | 10ML | Syrup | BID |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 30 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ], DOXYCYCLINE CAPSULE 100MG[ DOXYCYCLINE | 100MG | Capsule | BID |  For 14 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 30 Days  ]","FERROUS GLUCONATE  SYRUP[ TOT-HEMA (IN AMPOULES) | 10ML | Syrup ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], DOXYCYCLINE CAPSULE 100MG[ DOXYCYCLINE | 100MG | Capsule ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ]",,,15-06-2023,15-06-2023,,,10,OPD,
7515,15-06-2023,awoshie ,68 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",,,15-06-2023,15-06-2023,,,20,OPD,
7517,15-06-2023,awoshie,59 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",,,15-06-2023,15-06-2023,,,20,OPD,
7518,15-06-2023,APLUKU,50 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, A01.0 [Typhoid fever]  ==> OLD, K29.1 [Other acute gastritis]  ==> OLD",No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | OD |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 30 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], POTASSIUM CITRATE MIXTURE BP[ MIST POT CIT | 200ML | Mixture | TID |  For 10 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 30 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], POTASSIUM CITRATE MIXTURE BP[ MIST POT CIT | 200ML | Mixture ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ]",,,15-06-2023,15-06-2023,,,25,OPD,
7520,15-06-2023,albekuman,73 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,15-06-2023,15-06-2023,,,20,OPD,
7521,15-06-2023,weija,61 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, R00.0 [Tachycardia, unspecified]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], ATENOLOL TABLET 50MG[ ATENOLOL | 50MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ATENOLOL TABLET 50MG[ ATENOLOL | 50MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,15-06-2023,15-06-2023,,,10,OPD,
7522,15-06-2023,gbawe bulemi,71 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,15-06-2023,15-06-2023,,,20,OPD,3143/16
7523,15-06-2023,mallam  government school,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,15-06-2023,15-06-2023,,,10,OPD,
7524,15-06-2023,"TUBA, ROUNDABOUT",68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD, M54.4 [Lumbago with sciatica]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,15-06-2023,15-06-2023,,,20,OPD,
7540,15-06-2023,KASOA,57 Year(s),Male,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,15-06-2023,15-06-2023,,,0,OPD,
7548,15-06-2023,mallam,66 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ], WARFARIN 5MG[  |  |  ]",,,15-06-2023,15-06-2023,,,20,OPD,
7553,15-06-2023,"WEIJA, DJAMAN",60 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,A02.25 [Salmonella pyelonephritis]  ==> OLD,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,15-06-2023,15-06-2023,,,25,OPD,
7557,15-06-2023,WEIJA UPPER ,49 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, E78.5 [Hyperlipidaemia, unspecified]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",,,15-06-2023,15-06-2023,,,25,OPD,
7585,15-06-2023,tema,56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, K37.00 [Unspecified appendicitis]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ], ALKA 5  SYRUP[ ALKA 5  | 100ML | Syrup | TID |  For 10 Days  ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], ALKA 5  SYRUP[ ALKA 5  | 100ML | Syrup ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet ]",,,15-06-2023,15-06-2023,,,20,OPD,
7648,15-06-2023,ABLEKUMAH-AGAPE,73 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TDS |  For 10 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule | BID |  For 10 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,15-06-2023,15-06-2023,,,20,OPD,16230/19 mr-7b-i4-62
7651,15-06-2023,AYIGBE TOWN,35 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,MEDI03A [Diabetes - Complicated >=12 Yrs]  ==> OLD,,No,Insured,,,,,15-06-2023,15-06-2023,,,30,OPD,
7715,15-06-2023,"MALLAM , BEHIND LAFA POLICE STATION ",66 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, R00.0 [Tachycardia, unspecified]  ==> OLD, Z86.31 [Personal history of diabetic foot ulcer]  ==> OLD",No,Insured,"GENTAMICIN   INJECTION 80MG[ GENTAMICIN  | 80MG/2ML | Injection | OD |  For 3 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet | OD |  For 30 Days  ]","GENTAMICIN   INJECTION 80MG[ GENTAMICIN  | 80MG/2ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet ]",,,15-06-2023,15-06-2023,,,20,OPD,
7728,15-06-2023,upper weija,89 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ], IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule ]",,,15-06-2023,15-06-2023,,,20,OPD,
7735,15-06-2023,NIC,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, A54.02 [Gonococcal vulvovaginitis, unspecified]  ==> OLD, B37.4 [Candidiasis of other urogenital sites]  ==> OLD, H65.01 [Acute serous otitis media, right ear]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD, E16.9 [Disorder of pancreatic internal secretion, unspecified]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], CLOTRIMAZOLE  PESSARY 200MG[ CLOTRIMAZOLE | 200MG | Tablet | Nocte |  For 6 Days  ], FLUCONAZOLE CAPSULE 150MG[ FLUCONAZOLE | 150MG | Capsule | OD |  For 1 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BID |  For 7 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TID |  For 10 Days  ], DOXYCYCLINE CAPSULE 100MG[ DOXYCYCLINE | 100MG | Capsule | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | T","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], CLOTRIMAZOLE  PESSARY 200MG[ CLOTRIMAZOLE | 200MG | Tablet ], FLUCONAZOLE CAPSULE 150MG[ FLUCONAZOLE | 150MG | Capsule ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], DOXYCYCLINE CAPSULE 100MG[ DOXYCYCLINE | 100MG | Capsule ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet ]",,,15-06-2023,15-06-2023,,,20,OPD,
7753,15-06-2023,ABLEKUMA AGAPE,68 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD,,No,Insured,,,,,15-06-2023,15-06-2023,,,30,OPD,
7832,15-06-2023,DANKUMAN,79 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | Daily |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,15-06-2023,15-06-2023,,,0,OPD,
7881,15-06-2023,ABLEKUMAH OLEBU,51 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD,,No,Non-Insured,,,TRADER,,15-06-2023,15-06-2023,,,50,OPD,
7893,15-06-2023,BORTIANOR,52 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> NEW,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],BUSINESS PERSON,,15-06-2023,15-06-2023,,,10,OPD,
7934,15-06-2023,MCCARHTY HILL DOWN,65 Year(s),Female,ACCIDENT & EMERGENCY,Detention for Observation Child,,No Outcome,NA ,E13.65 [Other specified diabetes mellitus with hyperglycemia]  ==> OLD,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], OMEPRAZOLE INJECTION 40MG[ OMEPRAZOLE | 40MG | Injection | Stat |  For 1 Days  ], RINGER'S LACTATE SOLUTION[ RINGERS | 500ML | Infusion | Stat |  For 1 Days  ], HYOSCINE BUTYLBROMIDE INJECTION 20MG[ BUSCOPAN | 20MG/ML | Injection | Stat |  For 1 Days  ], METOCLOPRAMIDE INJECTION 10MG[ METOCLOPRAMIDE | 10MG/2ML | Injection | TDS |  For 1 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], OMEPRAZOLE INJECTION 40MG[ OMEPRAZOLE | 40MG | Injection ], RINGER'S LACTATE SOLUTION[ RINGERS | 500ML | Infusion ], HYOSCINE BUTYLBROMIDE INJECTION 20MG[ BUSCOPAN | 20MG/ML | Injection ], METOCLOPRAMIDE INJECTION 10MG[ METOCLOPRAMIDE | 10MG/2ML | Injection ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",Pensioner,,15-06-2023,15-06-2023,,,180,OPD,"26715/18 , MR-9B-B6-57"
7946,15-06-2023,KASOA OTAMENS,67 Year(s),Male,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,15-06-2023,15-06-2023,,,0,OPD,
8098,14-06-2023,NEW  WEIJA,61 Year(s),Female,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.69 [Diabetes mellitus due to underlying condition with other specified complication]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 90 Days  ]","AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,14-06-2023,14-06-2023,,,10,OPD,
8111,14-06-2023,SANTA MARIA,59 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD,,No,Insured,,,,,14-06-2023,14-06-2023,,,20,OPD,
8122,14-06-2023,awoshie,54 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, Z86.31 [Personal history of diabetic foot ulcer]  ==> NEW, B50.9 [Plasmodium falciparum malaria, unspecified]  ==> OLD",No,Insured,"ANTI TETANUS SERUM1500IU[ ATS | 1500IU/ML | Injection | OD |  For 1 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], ARTEMETHER+LUMEFANTRIN 80/480MG(LONART)[  | 80mg/480mg | Tablet | BID |  For 3 Days  ],  TABLET SECNIDAZOLE 1G[ SECNIDAZOLE | 1G | Tablet | OD |  For 1 Days  ]","ANTI TETANUS SERUM1500IU[ ATS | 1500IU/ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], ARTEMETHER+LUMEFANTRIN 80/480MG(LONART)[  | 80mg/480mg | Tablet ],  TABLET SECNIDAZOLE 1G[ SECNIDAZOLE | 1G | Tablet ]",,,14-06-2023,14-06-2023,,,20,OPD,
8142,14-06-2023,"ANYAA 
DEEPER LIFE",58 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, F06.4 [Organic anxiety disorder]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,14-06-2023,14-06-2023,,,20,OPD,
8315,14-06-2023,GALILEA,52 Year(s),Male,DIETERAPY,General Consultation Adult,,No Outcome,NA ,MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD,,No,Insured,,,,,14-06-2023,14-06-2023,,,30,OPD,
8613,14-06-2023,new weija azumah,65 Year(s),Male,DIETERAPY,General Consultation Adult,,No Outcome,NA ,MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD,,No,Insured,,,,,14-06-2023,14-06-2023,,,20,OPD,
8768,13-06-2023,AKWELEY NEW TOWN,52 Year(s),Male,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 30 Days  ]","PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",,,13-06-2023,13-06-2023,,,0,OPD,
8779,13-06-2023,mc carthy,57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]",,,,13-06-2023,13-06-2023,,,20,OPD,
8781,13-06-2023,tetegu,48 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,13-06-2023,13-06-2023,,,20,OPD,
8785,13-06-2023,tetegu,52 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 30 Days  ], WARFARIN 5MG[  |  |  | OD |  For 30 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], WARFARIN 5MG[  |  |  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ]",,,13-06-2023,13-06-2023,,,10,OPD,
8786,13-06-2023,BUBUASIE,64 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], WARFARIN 5MG[  |  |  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,13-06-2023,13-06-2023,,,25,OPD,
8787,13-06-2023,gbawe top base,62 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, E78.5 [Hyperlipidaemia, unspecified]  ==> OLD",No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",,,13-06-2023,13-06-2023,,,10,OPD,
8788,13-06-2023,kasoa,55 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,J00.00 [Acute nasopharyngitis [common cold]]  ==> OLD,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",,,13-06-2023,13-06-2023,,,10,OPD,
8791,13-06-2023,DANSOMAN-BEACH,62 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, A02.25 [Salmonella pyelonephritis]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], ALKA 5  SYRUP[ ALKA 5  | 100ML | Syrup | TID |  For 10 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], ALKA 5  SYRUP[ ALKA 5  | 100ML | Syrup ]",,,13-06-2023,13-06-2023,,,10,OPD,
8795,13-06-2023,kasoa,59 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TDS |  For 10 Days  ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule | BID |  For 10 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet ]",,,13-06-2023,13-06-2023,,,20,OPD,
8799,13-06-2023,gbawe,66 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], WARFARIN 5MG[  |  |  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,13-06-2023,13-06-2023,,,20,OPD,
8800,13-06-2023,"gbawe
bulemi",72 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, K29.1 [Other acute gastritis]  ==> OLD",No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TID |  For 10 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",,,13-06-2023,13-06-2023,,,20,OPD,
8802,13-06-2023,"ANYAA ,. NIC - TOP ",40 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, A01.0 [Typhoid fever]  ==> OLD, A02.25 [Salmonella pyelonephritis]  ==> OLD",Yes,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], ALKA 5  SYRUP[ ALKA 5  | 100ML | Syrup | TID |  For 10 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], ALKA 5  SYRUP[ ALKA 5  | 100ML | Syrup ]",,,13-06-2023,13-06-2023,,,20,OPD,
8838,13-06-2023,weija choice,56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ]",,,,13-06-2023,13-06-2023,,,60,OPD,
8911,13-06-2023,MALLAM JUNCTION,77 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | BID |  For 90 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 90 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], WARFARIN 5MG[  |  |  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ]",,,13-06-2023,13-06-2023,,,25,OPD,
8914,13-06-2023,"GBAWE , ",73 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], WARFARIN 5MG[  |  |  | OD |  For 30 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], WARFARIN 5MG[  |  |  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ]",,,13-06-2023,13-06-2023,,,10,OPD,
8915,13-06-2023,kasoa cp,72 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | BID |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], WARFARIN 5MG[  |  |  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,13-06-2023,13-06-2023,,,20,OPD,
8917,13-06-2023,NEW BORTIANOR,53 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ]",,,13-06-2023,13-06-2023,,,20,OPD,
9011,13-06-2023,SCC- AZUMA,65 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], WARFARIN 5MG[  |  |  | BID |  For 30 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], WARFARIN 5MG[  |  |  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,13-06-2023,13-06-2023,,,20,OPD,
9014,13-06-2023,"GBAWE , CP ",62 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, F06.4 [Organic anxiety disorder]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], WARFARIN 5MG[  |  |  ]",TRADER,,13-06-2023,13-06-2023,,,20,OPD,
9019,13-06-2023,GBAWE,89 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | OD |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], WARFARIN 5MG[  |  |  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ]",,,13-06-2023,13-06-2023,,,20,OPD,
9056,13-06-2023,ABLEKUMA,61 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"Z86.31 [Personal history of diabetic foot ulcer]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet | BID |  For 14 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet ]",,,13-06-2023,13-06-2023,,,70,OPD,
9082,13-06-2023,"KASOA, SAWMILL",37 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,13-06-2023,13-06-2023,,,10,OPD,
9097,13-06-2023,AMASAMAN,50 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,13-06-2023,13-06-2023,,,50,OPD,
9108,13-06-2023,awoshie,61 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | BID |  For 30 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TID |  For 10 Days  ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule | BID |  For 10 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",,,13-06-2023,13-06-2023,,,20,OPD,
9156,13-06-2023,MATAHEKO,83 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD,,No,Insured,,,,,13-06-2023,13-06-2023,,,30,OPD,
9202,13-06-2023,ANYAA NIC,58 Year(s),Female,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> NEW,,No,Insured,,,,,13-06-2023,13-06-2023,,,10,OPD,
9410,12-06-2023,ABLEKUMA-AGAPE,71 Year(s),Female,SURGICAL OPD,Surgical Consultation ,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> NEW,"E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW, I10.00 [Essential (primary) hypertension]  ==> NEW",No,Insured,"AMOXICILLIN+CLAVULINIC ACID TABLET 625MG[ AMOKSICLAV | 500MG+125MG | Tablet | BID |  For 7 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 15 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 15 Days  ]","AMOXICILLIN+CLAVULINIC ACID TABLET 625MG[ AMOKSICLAV | 500MG+125MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,12-06-2023,12-06-2023,,,30,OPD,
9411,12-06-2023,"NEW BORTIANOR
LANE 2",53 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ]",,,12-06-2023,12-06-2023,,,10,OPD,
9412,12-06-2023,SCC-DVLA,73 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"A01.0 [Typhoid fever]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD, F06.4 [Organic anxiety disorder]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | BID |  For 90 Days  ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet | BID |  For 5 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TDS |  For 10 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 10 Days  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], WARFARIN 5MG[  |  |  ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ]",,,12-06-2023,12-06-2023,,,10,OPD,
9431,12-06-2023,UPPER WEIJA,48 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,12-06-2023,12-06-2023,,,20,OPD,
9437,12-06-2023,WATER WAYS ,79 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,,,,,12-06-2023,12-06-2023,,,20,OPD,
9438,12-06-2023,"DARKUMAN
MASALAKYI",60 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, K27.2 [Peptic ulcer, site unspecified: Acute with both haemorrhage and perforation]  ==> OLD",No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TDS |  For 10 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule | BID |  For 10 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet | BID |  For 5 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet ]",,,12-06-2023,12-06-2023,,,10,OPD,
9442,12-06-2023,ksaoa,75 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,12-06-2023,12-06-2023,,,20,OPD,
9444,12-06-2023,NEW BORTIANOR,55 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.31 [Personal history of diabetic foot ulcer]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 30 Days  ], WARFARIN 5MG[  |  |  | OD |  For 30 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], POVIDONE+METRONIDAZOLE (DREZ) OINTMENT 30G[ DREZ OINTMENT | 30G | Ointment | BID |  For 10 Days  ]",,TRADER,,12-06-2023,12-06-2023,,,10,OPD,23545/20
9446,12-06-2023,kasoa new town,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], WARFARIN 5MG[  |  |  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,12-06-2023,12-06-2023,,,20,OPD,
9449,12-06-2023,ABLEKUMA FANMILK,54 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | BID |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ]",,,,12-06-2023,12-06-2023,,,20,OPD,
9450,12-06-2023,ablekuman,52 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,12-06-2023,12-06-2023,,,10,OPD,
9473,12-06-2023,gbawe top base,70 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | OD |  For 90 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | OD |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], WARFARIN 5MG[  |  |  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,12-06-2023,12-06-2023,,,20,OPD,
9475,12-06-2023,tabola alaje,69 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,12-06-2023,12-06-2023,,,20,OPD,
9478,12-06-2023,MALLAM JULIKART,49 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD, A01.0 [Typhoid fever]  ==> OLD, H93.1 [Tinnitus]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], CINNARIZINE (STUGERON) 25MG[ STUGERON | 25MG | Tablet | OD |  For 90 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TID |  For 10 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], CINNARIZINE (STUGERON) 25MG[ STUGERON | 25MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet ]",NAIL TECHNICIAN,,12-06-2023,12-06-2023,,,20,OPD,
9485,12-06-2023,sowutuom ,64 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, B50.9 [Plasmodium falciparum malaria, unspecified]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ARTEMETHER+LUMEFANTRIN 80/480MG(LONART)[  | 80mg/480mg | Tablet | BID |  For 3 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ARTEMETHER+LUMEFANTRIN 80/480MG(LONART)[  | 80mg/480mg | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,12-06-2023,12-06-2023,,,70,OPD,
9539,12-06-2023,KOKROBITE,63 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | OD |  For 1 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], WARFARIN 5MG[  |  |  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,12-06-2023,12-06-2023,,,20,OPD,
9560,12-06-2023,"MCCARTHY HILLS 
BENJES",65 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Non-insulin-dependent diabetes mellitus: Without complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,,,TRADER,,12-06-2023,12-06-2023,,,50,OPD,
9663,12-06-2023,south mccharthy,74 Year(s),Male,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,12-06-2023,12-06-2023,,,0,OPD,
9681,12-06-2023,DOMEABRA ,54 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ]",,,12-06-2023,12-06-2023,,,25,OPD,
9686,12-06-2023,AMANFROM-GALILEA,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,12-06-2023,12-06-2023,,,20,OPD,
9690,12-06-2023,TETEGU,69 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, K27.2 [Peptic ulcer, site unspecified: Acute with both haemorrhage and perforation]  ==> OLD",No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | BID |  For 90 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TID |  For 10 Days  ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule | BID |  For 10 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], WARFARIN 5MG[  |  |  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule ]",,,12-06-2023,12-06-2023,,,10,OPD,
9720,12-06-2023,"KASOA,ANNOR TOWN",61 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, E78.5 [Hyperlipidaemia, unspecified]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD, K85.0 [Idiopathic acute pancreatitis]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TID |  For 10 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 1 Days  ], WARFARIN 5MG[  |  |  | OD |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], WARFARIN 5MG[  |  |  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",TRADER,,12-06-2023,12-06-2023,,,20,OPD,
9754,12-06-2023,WEIJA-SCH JUNCTION,56 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> NEW, B50.9 [Plasmodium falciparum malaria, unspecified]  ==> OLD, A01.0 [Typhoid fever]  ==> OLD, K29.1 [Other acute gastritis]  ==> OLD, A50.5 [Other late congenital syphilis, symptomatic]  ==> OLD",No,Insured,"ARTEMETHER+LUMEFANTRIN 80/480MG(LONART)[  | 80mg/480mg | Tablet | BID |  For 3 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | BID |  For 10 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet | BID |  For 5 Days  ], BENZATHINE PENICILIN INJECTION 2.4MU[ BENZATHINE PENICILIN | 2.4MU | Injection | OD |  For 1 Days  ], DOXYCYCLINE CAPSULE 100MG[ DOXYCYCLINE | 100MG | Capsule | BID |  For 14 Days  ], ARTESUNATE INJECTION 120MG[ ARTESUNATE | 120MG | Injection | OD |  For 1 Days  ]","ARTEMETHER+LUMEFANTRIN 80/480MG(LONART)[  | 80mg/480mg | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet ], BENZATHINE PENICILIN INJECTION 2.4MU[ BENZATHINE PENICILIN | 2.4MU | Injection ], DOXYCYCLINE CAPSULE 100MG[ DOXYCYCLINE | 100MG | Capsule ], ARTESUNATE INJECTION 120MG[ ARTESUNATE | 120MG | Injection ]",,,12-06-2023,12-06-2023,,,20,OPD,
9756,12-06-2023,KWABENYA,44 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.319 [Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy without macular edema]  ==> NEW,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ],,,,12-06-2023,12-06-2023,,,10,OPD,
9788,12-06-2023,FANMILK,30 Year(s),Female,ANC CLINIC ,ANC Review Consultation ,,No Outcome,NA ,"O24.419 [Gestational diabetes mellitus in pregnancy, unspecified control]  ==> NEW",,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | TDS |  For 14 Days  ], MICONAZOLE OVULE 40OMG[ MICONAZOLE PESS | 400MG | Ovule | Stat |  For 1 Days  ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet | BDS |  For 7 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], MICONAZOLE OVULE 40OMG[ MICONAZOLE PESS | 400MG | Ovule ], CEFUROXIME TABLET 500MG[ CEFUROXIME | 500MG | Tablet ]",,,12-06-2023,12-06-2023,,,0,OPD,
9867,12-06-2023,"AWOSHIE
BAAHYARD",25 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.10 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> OLD,"A01.0 [Typhoid fever]  ==> OLD, B35.4 [Tinea corporis]  ==> OLD",No,Non-Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ], FEXOFENADINE TABLET 120MG (ZYFEN)[ ZYFEN | 120MG | Tablet | OD |  For 10 Days  ], BETAMETHASONE DIPROPIONATE LOTION[ DIPROSON  | 0.05% 30G | Lotion | BID |  For 10 Days  ], GRISEOFULVIN TABLET 500MG[ GRISEOVULFIN | 500MG | Tablet | BID |  For 14 Days  ]",,,,12-06-2023,12-06-2023,,,75,OPD,
10024,12-06-2023,GBAWE CP,71 Year(s),Male,INJECTION/DRESSING ROOM,Change of Dressing Adult,,No Outcome,NA ,E08.621 [Diabetes mellitus due to underlying condition with foot ulcer]  ==> NEW,,No,Insured,,,,,12-06-2023,12-06-2023,,,10,OPD,
10307,10-06-2023,ABLEKUMA,47 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,10-06-2023,10-06-2023,,,10,OPD,
10414,09-06-2023,GBAWE BULEMI JUNCTION,66 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> NEW,,No,Insured,,,,,09-06-2023,09-06-2023,,,20,OPD,
10436,09-06-2023,KWASHIEMAN NAADU SHEET,60 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,,,TRADER,,09-06-2023,09-06-2023,,,20,OPD,
10560,09-06-2023,MACARTHEY HILL,57 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.311 [Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy with macular edema]  ==> NEW,,No,Insured,"INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | Stat |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection | Stat |  For 1 Days  ]","INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], GIVING SET FOR INFUSION[ GIVING SET  |  | Injection ]",,,09-06-2023,09-06-2023,,,30,OPD,
10752,09-06-2023,NEW APLAKU,69 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> NEW,I10. [Essential (primary) hypertension]  ==> NEW,No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily AC |  For 30 Days  ]","CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,09-06-2023,09-06-2023,,,0,OPD,
10954,08-06-2023,KASOA ,76 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,"N39.0 [Urinary tract infection, site not specified]  ==> NEW, M79.1 [Myalgia]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 7 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | TID |  For 7 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ]",Pensioner,,08-06-2023,08-06-2023,,,20,OPD,
10979,08-06-2023,KASOA,43 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ]",,,08-06-2023,08-06-2023,,,25,OPD,
10998,08-06-2023,BARRIER ,50 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ]",,,08-06-2023,08-06-2023,,,20,OPD,
10999,08-06-2023,bubueshie,55 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"M79.1 [Myalgia]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], WARFARIN 5MG[  |  |  | OD |  For 90 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 90 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], WARFARIN 5MG[  |  |  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,08-06-2023,08-06-2023,,,20,OPD,
11001,08-06-2023,ABLEKUMAH,45 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, D46.4 [Refractory anaemia, unspecified]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule | OD |  For 30 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], IRON(III)POLYMALTOSE COMPLEX CAPSULE[ FERRUM | 100mg | Capsule ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",,,08-06-2023,08-06-2023,,,20,OPD,
11002,08-06-2023,santa marie,67 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, M79.1 [Myalgia]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,08-06-2023,08-06-2023,,,20,OPD,
11003,08-06-2023,"WEIJA
MANDELA",49 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, A20.7 [Septicaemic plague]  ==> OLD, B35.4 [Tinea corporis]  ==> OLD, B82.0 [Intestinal helminthiasis, unspecified]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], GRISEOFULVIN TABLET 500MG[ GRISEOVULFIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], WARFARIN 5MG[  |  |  | OD |  For 90 Days  ], BETAMETHASONE DIPROPIONATE[ DIPROSON  | 0.05% 30G | Cream | BID |  For 10 Days  ], ALBENDAZOLE TABLET 400MG[ ALBENDAZOLE | 400MG | Tablet | OD |  For 1 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], GRISEOFULVIN TABLET 500MG[ GRISEOVULFIN | 500MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], WARFARIN 5MG[  |  |  ], BETAMETHASONE DIPROPIONATE[ DIPROSON  | 0.05% 30G | Cream ], ALBENDAZOLE TABLET 400MG[ ALBENDAZOLE | 400MG | Tablet ]",,,08-06-2023,08-06-2023,,,10,OPD,
11004,08-06-2023,ABLEKUIMA ,70 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet ], WARFARIN 5MG[  |  |  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,08-06-2023,08-06-2023,,,20,OPD,
11006,08-06-2023,red top,55 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, I20.9 [Angina pectoris, unspecified]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, I30.9 [Acute pericarditis, unspecified]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | BID |  For 90 Days  ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BID |  For 7 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], WARFARIN 5MG[  |  |  ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ]",,,08-06-2023,08-06-2023,,,10,OPD,
11007,08-06-2023,weija,65 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TID |  For 10 Days  ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule | BID |  For 10 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet ]",,,08-06-2023,08-06-2023,,,20,OPD,
11120,08-06-2023,ABLEKUMA,55 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,CARPENTER,,08-06-2023,08-06-2023,,,25,OPD,
11121,08-06-2023,agape,65 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, A02.25 [Salmonella pyelonephritis]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], ALKA 5  SYRUP[ ALKA 5  | 100ML | Syrup | TID |  For 10 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], ALKA 5  SYRUP[ ALKA 5  | 100ML | Syrup ]",,,08-06-2023,08-06-2023,,,10,OPD,
11123,08-06-2023,weija,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, M79.1 [Myalgia]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]",,,,08-06-2023,08-06-2023,,,20,OPD,
11130,08-06-2023,dansoman,69 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> NEW",No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TID |  For 10 Days  ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule | BID |  For 10 Days  ],  TABLET SECNIDAZOLE 1G[ SECNIDAZOLE | 1G | Tablet | OD |  For 1 Days  ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet | BID |  For 5 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule ],  TABLET SECNIDAZOLE 1G[ SECNIDAZOLE | 1G | Tablet ], HYOSCINE BUTYLBROMIDE TABLET 10MG[ BUSCOPAN | 10MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",,,08-06-2023,08-06-2023,,,20,OPD,
11132,08-06-2023,upper weija,52 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], WARFARIN 5MG[  |  |  | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], WARFARIN 5MG[  |  |  ]",,,08-06-2023,08-06-2023,,,20,OPD,
11161,08-06-2023,"KASOA
NEW TOWN",71 Year(s),Male,GENERAL OPD,Review Consultation Adult,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> NEW,No,Insured,AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 30 Days  ],AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ],pension,,08-06-2023,08-06-2023,,,20,OPD,
11181,08-06-2023,FIJAI,70 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> NEW,,No,Insured,"FEFE POWDER[ HERBAL |  | Powder | BID |  For 14 Days  ], LIPPIA TEA (SATCHETS) ()[ LIPPIA TEA (SATCHETS) |  |  | Nocte |  For 10 Days  ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","FEFE POWDER[ HERBAL |  | Powder ], LIPPIA TEA (SATCHETS) ()[ LIPPIA TEA (SATCHETS) |  |  ], GLIMEPERIDE TABLET 2MG[ GLIMEPERIDE | 2MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",none,,08-06-2023,08-06-2023,,,20,OPD,
11183,08-06-2023,KASOA,66 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, I21.A9 [Other myocardial infarction type]  ==> OLD, I42.0 [Dilated cardiomyopathy]  ==> OLD, L03.1 [Cellulitis of other parts of limb]  ==> OLD, B35.4 [Tinea corporis]  ==> OLD, R00.1 [Bradycardia, unspecified]  ==> OLD, F06.4 [Organic anxiety disorder]  ==> OLD",No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], WARFARIN 5MG[  |  |  | BID |  For 30 Days  ], GRISEOFULVIN TABLET 500MG[ GRISEOVULFIN | 500MG | Tablet | BID |  For 14 Days  ], BETAMETHASONE DIPROPIONATE[ DIPROSON  | 0.05% 30G | Cream | BID |  For 10 Days  ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet | BID |  For 14 Days  ], AMITRIPTYLINE TABLET 50MG[ AMITRIPTYLINE | 50MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], WARFARIN 5MG[  |  |  ], GRISEOFULVIN TABLET 500MG[ GRISEOVULFIN | 500MG | Tablet ], BETAMETHASONE DIPROPIONATE[ DIPROSON  | 0.05% 30G | Cream ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet ], AMITRIPTYLINE TABLET 50MG[ AMITRIPTYLINE | 50MG | Tablet ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ]",,,08-06-2023,08-06-2023,,,10,OPD,
11187,08-06-2023,NEW GBAWE CP,67 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, L29.9 [Pruritus, unspecified]  ==> OLD, E78.5 [Hyperlipidaemia, unspecified]  ==> OLD, M10.09 [Idiopathic gout, multiple sites]  ==> OLD, Z87.442 [Personal history of urinary calculi]  ==> OLD, F06.4 [Organic anxiety disorder]  ==> OLD, B82.0 [Intestinal helminthiasis, unspecified]  ==> OLD",No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 30 Days  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], FEXOFENADINE TABLET 120MG (ZYFEN)[ ZYFEN | 120MG | Tablet | OD |  For 10 Days  ], HYDROCORTISONE CREAM 1%[ HYDROCORTISONE | 1% 15G | Cream | BID |  For 10 Days  ], ALBENDAZOLE TABLET 400MG[ ALBENDAZOLE | 400MG | Tablet | OD |  For 1 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], FEXOFENADINE TABLET 120MG (ZYFEN)[ ZYFEN | 120MG | Tablet ], HYDROCORTISONE CREAM 1%[ HYDROCORTISONE | 1% 15G | Cream ], ALBENDAZOLE TABLET 400MG[ ALBENDAZOLE | 400MG | Tablet ]",,,08-06-2023,08-06-2023,,,65,OPD,
11189,08-06-2023,kasoa ofankor,64 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], WARFARIN 5MG[  |  |  ]",,,08-06-2023,08-06-2023,,,20,OPD,
11194,08-06-2023,mccarthy,67 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | BID |  For 90 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], WARFARIN 5MG[  |  |  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,08-06-2023,08-06-2023,,,20,OPD,
11197,08-06-2023,gbawe top base,77 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 90 Days  ]",,,,08-06-2023,08-06-2023,,,20,OPD,
11201,08-06-2023,NEW BORTIANOR,71 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], WARFARIN 5MG[  |  |  | BID |  For 90 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 90 Days  ]","ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], WARFARIN 5MG[  |  |  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ]",,,08-06-2023,08-06-2023,,,20,OPD,
11204,08-06-2023,BULEMIN,76 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",,,08-06-2023,08-06-2023,,,20,OPD,
11207,08-06-2023,tetegu,65 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, M54.4 [Lumbago with sciatica]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository | BID |  For 5 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,08-06-2023,08-06-2023,,,20,OPD,
11296,08-06-2023,new applaku,60 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, I69.4 [Sequelae of stroke, not specified as haemorrhage or infarction]  ==> OLD",No,Non-Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BDS |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ]",,,,08-06-2023,08-06-2023,,,20,OPD,
11354,08-06-2023,kokrobite,58 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",,,08-06-2023,08-06-2023,,,10,OPD,
11625,07-06-2023,DODI MEMPEASEM AT YAO  HOUSE,79 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,N34.1 [Nonspecific urethritis]  ==> NEW,No,Insured,"CIPROFLOXACIN+TINIDAZOLE TABLET[ CIPROLEX- TZ | 500MG+600MG | Tablet | BDS |  For 7 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 15 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Mane |  For 30 Days  ]","CIPROFLOXACIN+TINIDAZOLE TABLET[ CIPROLEX- TZ | 500MG+600MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,07-06-2023,07-06-2023,,,20,OPD,
11678,07-06-2023,"LL JINIJINI,PRESBY SCHOOL",75 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.42 [Type 2 diabetes mellitus with diabetic polyneuropathy]  ==> OLD,"R60.9 [Oedema, unspecified]  ==> NEW, I10.00 [Essential (primary) hypertension]  ==> OLD",No,Insured,"FUROSEMIDE TABLET 40MG[ FUROSEMIDE | 40MG | Tablet | Daily |  For 30 Days  ], CELECOXIB[ CELEBREX | 200MG |  | BDS |  For 7 Days  ]","FUROSEMIDE TABLET 40MG[ FUROSEMIDE | 40MG | Tablet ], CELECOXIB[ CELEBREX | 200MG |  ]",,,07-06-2023,07-06-2023,,,20,OPD,
11730,07-06-2023,mallam,77 Year(s),Male,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ]","NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], GLIMEPERIDE TABLET 4MG[ GLIMEPERIDE | 4MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,07-06-2023,07-06-2023,,,0,OPD,
11856,07-06-2023,ABLEKUMA-ODUMN,35 Year(s),Female,WELLNESS CLINIC,General Consultation ,,No Outcome,NA ,R73.03 [Prediabetes]  ==> OLD,,No,Insured,,,seamstress,,07-06-2023,07-06-2023,,,0,OPD,
11918,07-06-2023,"SANTA MARIA
DRUG STORE",71 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> NEW,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,07-06-2023,07-06-2023,,,20,OPD,
11967,07-06-2023,"TATOP
ICGC CHURCH",49 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.69 [Type 2 diabetes mellitus with other specified complication]  ==> NEW,M79.1 [Myalgia]  ==> NEW,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 30 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BDS |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ]",Fashion Designer,,07-06-2023,07-06-2023,,,60,OPD,
12045,07-06-2023,kwashieman,47 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,07-06-2023,07-06-2023,,,0,OPD,
12098,07-06-2023,ODORKOR,84 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ]","CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,07-06-2023,07-06-2023,,,0,OPD,
12119,07-06-2023,TETEGU,35 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,"R63.0 [Anorexia]  ==> NEW, F51.01 [Primary insomnia]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 30 Days  ], MULTIVITAMIN+MINERALS[ EZOTOL |  | Capsule | Daily |  For 30 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], MULTIVITAMIN+MINERALS[ EZOTOL |  | Capsule ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ]",,,07-06-2023,07-06-2023,,,10,OPD,
12237,07-06-2023,"WEIJA , BLOCK FACTORY ",55 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.49 [Diabetes mellitus due to underlying condition with other diabetic neurological complication]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",Unemployed,,07-06-2023,07-06-2023,,,10,OPD,
12406,06-06-2023,"NEW BORTIANOR
BABA DOGO",71 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,06-06-2023,06-06-2023,,,20,OPD,
12424,06-06-2023,"LL JINIJINI,PRESBY SCHOOL",75 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> NEW,I10.00 [Essential (primary) hypertension]  ==> NEW,No,Insured,"AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | Daily |  For 3 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | Daily |  For 30 Days  ]",,,,06-06-2023,06-06-2023,,,50,OPD,
12464,06-06-2023,mallam jut,51 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet | OD |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",,,06-06-2023,06-06-2023,,,20,OPD,
12472,06-06-2023,gbawe ,68 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,06-06-2023,06-06-2023,,,10,OPD,
12473,06-06-2023,tetegu,52 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,06-06-2023,06-06-2023,,,10,OPD,
12474,06-06-2023,scc red top,57 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, K29.1 [Other acute gastritis]  ==> OLD, J18.0 [Bronchopneumonia, unspecified]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BID |  For 7 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TID |  For 10 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ]",,,06-06-2023,06-06-2023,,,10,OPD,
12483,06-06-2023,mallam top base,61 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD, M54.4 [Lumbago with sciatica]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository ]",,,06-06-2023,06-06-2023,,,20,OPD,
12488,06-06-2023,MCCARTHY HILL,56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, F06.4 [Organic anxiety disorder]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | OD |  For 90 Days  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], WARFARIN 5MG[  |  |  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ]",,,06-06-2023,06-06-2023,,,20,OPD,
12508,06-06-2023,SOUTH MC-CARTHY ,69 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], WARFARIN 5MG[  |  |  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,06-06-2023,06-06-2023,,,20,OPD,
12510,06-06-2023,kwashieman,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, F06.4 [Organic anxiety disorder]  ==> OLD",No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",Retired,,06-06-2023,06-06-2023,,,20,OPD,
12512,06-06-2023,sakaman,63 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, G24.3 [Spasmodic torticollis]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], PREDNISOLONE TABLET 5MG[ PREDNISOLONE | 5MG | Tablet | OD |  For 10 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], PREDNISOLONE TABLET 5MG[ PREDNISOLONE | 5MG | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,06-06-2023,06-06-2023,,,20,OPD,
12513,06-06-2023,ODORKOR-BUSIA,60 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,06-06-2023,06-06-2023,,,20,OPD,159561
12516,06-06-2023,ODORKOR,45 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,06-06-2023,06-06-2023,,,20,OPD,
12518,06-06-2023,kasoa,62 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], WARFARIN 5MG[  |  |  | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]",,TRADER,,06-06-2023,06-06-2023,,,20,OPD,
12520,06-06-2023,ANYAA,56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, A02.25 [Salmonella pyelonephritis]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, E78.5 [Hyperlipidaemia, unspecified]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 30 Days  ], WARFARIN 5MG[  |  |  | OD |  For 30 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ], ALKA 5  SYRUP[ ALKA 5  | 100ML | Syrup | TDS |  For 10 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], WARFARIN 5MG[  |  |  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], ALKA 5  SYRUP[ ALKA 5  | 100ML | Syrup ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",,,06-06-2023,06-06-2023,,,10,OPD,
12533,06-06-2023,WEIJA-MANDELA SCC,72 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet | OD |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,06-06-2023,06-06-2023,,,10,OPD,21620/19
12540,06-06-2023,mallam,59 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Non-Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,06-06-2023,06-06-2023,,,0,OPD,
12576,06-06-2023,kasoa,65 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | Daily |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ]","AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",,,06-06-2023,06-06-2023,,,0,OPD,
12580,06-06-2023,nyamitse,70 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD, F06.4 [Organic anxiety disorder]  ==> OLD, A01.0 [Typhoid fever]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TID |  For 10 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ],  TABLET SECNIDAZOLE 1G[ SECNIDAZOLE | 1G | Tablet | OD |  For 1 Days  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ],  TABLET SECNIDAZOLE 1G[ SECNIDAZOLE | 1G | Tablet ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ]",,,06-06-2023,06-06-2023,,,20,OPD,
12721,06-06-2023,"ABLEKUMA
JOMA",53 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.42 [Type 2 diabetes mellitus with diabetic polyneuropathy]  ==> NEW,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], METHYLCOBALAMIN + PREGABALIN[  | 1500MCG + 75MG | Tablet | OD |  For 14 Days  ]",,TRADER,,06-06-2023,06-06-2023,,,60,OPD,
12741,06-06-2023,asamankese kofipare,57 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, M10.09 [Idiopathic gout, multiple sites]  ==> OLD, A02.25 [Salmonella pyelonephritis]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, F06.4 [Organic anxiety disorder]  ==> OLD",No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], WARFARIN 5MG[  |  |  | BID |  For 90 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], ALKA 5  SYRUP[ ALKA 5  | 100ML | Syrup | BID |  For 10 Days  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], WARFARIN 5MG[  |  |  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], ALKA 5  SYRUP[ ALKA 5  | 100ML | Syrup ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ]",,,06-06-2023,06-06-2023,,,10,OPD,
12748,06-06-2023,"GBAWE
BULEMIN",29 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"E78.5 [Hyperlipidaemia, unspecified]  ==> NEW",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ]",,,06-06-2023,06-06-2023,,,20,OPD,
12752,06-06-2023,GBAWE  -GONSE,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, L03.1 [Cellulitis of other parts of limb]  ==> OLD, F06.4 [Organic anxiety disorder]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], WARFARIN 5MG[  |  |  | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], WARFARIN 5MG[  |  |  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ]",,,06-06-2023,06-06-2023,,,10,OPD,
12817,06-06-2023,ABLEKUMA-MANHIA,48 Year(s),Male,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> NEW,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],driver,,06-06-2023,06-06-2023,,,50,OPD,
12888,06-06-2023,awoshie,46 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",,,06-06-2023,06-06-2023,,,0,OPD,
12908,06-06-2023,"BLOCKFACTORY
SCC",59 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,06-06-2023,06-06-2023,,,0,OPD,
12909,06-06-2023,DANSOMAN-SAHARA,90 Year(s),Male,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | Nocte |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BDS |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,06-06-2023,06-06-2023,,,0,OPD,
12925,06-06-2023,NEW WEIJA ,50 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,Z86.31 [Personal history of diabetic foot ulcer]  ==> NEW,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet | BID |  For 14 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet ]",,,06-06-2023,06-06-2023,,,20,OPD,
12956,06-06-2023,Malam,63 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | Daily |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BDS |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ]","CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ]",,,06-06-2023,06-06-2023,,,0,OPD,
12988,06-06-2023,ABLEKUMA-MANHIA,48 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> NEW,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ],,driver,,06-06-2023,06-06-2023,,,50,OPD,
13032,06-06-2023,GALELIA MARKET,28 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,"E08.3299 [Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye]  ==> NEW",,No,Insured,INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ],INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ],student,,06-06-2023,06-06-2023,,,20,OPD,
13033,06-06-2023,NSAKINA,52 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,06-06-2023,06-06-2023,,,10,OPD,
13230,05-06-2023,"SCC , RED TOP",73 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | BID |  For 90 Days  ], WARFARIN 5MG[  |  |  | OD |  For 90 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ], WARFARIN 5MG[  |  |  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,05-06-2023,05-06-2023,,,10,OPD,
13232,05-06-2023,awoshie,70 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,05-06-2023,05-06-2023,,,20,OPD,
13234,05-06-2023,ablekuman agape,56 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, I20.9 [Angina pectoris, unspecified]  ==> OLD, I30.8 [Other forms of acute pericarditis]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BID |  For 7 Days  ],  TABLET SECNIDAZOLE 1G[ SECNIDAZOLE | 1G | Tablet | OD |  For 1 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet ],  TABLET SECNIDAZOLE 1G[ SECNIDAZOLE | 1G | Tablet ]",,,05-06-2023,05-06-2023,,,20,OPD,
13236,05-06-2023,MALLAM,58 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD, R00.1 [Bradycardia, unspecified]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | OD |  For 90 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TID |  For 10 Days  ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet | BID |  For 7 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | BID |  For 7 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], WARFARIN 5MG[  |  |  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], AMOXICILLIN+CLAVULANIC ACID TABLET 1G[ AMOKSICLAV | 875MG +125MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ]",,,05-06-2023,05-06-2023,,,20,OPD,
13254,05-06-2023,mccarthy,52 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"B50.9 [Plasmodium falciparum malaria, unspecified]  ==> OLD, I10.00 [Essential (primary) hypertension]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], ARTEMETHER+LUMEFANTRIN 80/480MG(LONART)[  | 80mg/480mg | Tablet | BID |  For 3 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], ARTEMETHER+LUMEFANTRIN 80/480MG(LONART)[  | 80mg/480mg | Tablet ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ]",,,05-06-2023,05-06-2023,,,10,OPD,
13255,05-06-2023,"KASOA , KULABULE",81 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, G44.321 [Chronic post-traumatic headache, intractable]  ==> OLD",No,Insured,"NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 30 Days  ]",,TRADER,,05-06-2023,05-06-2023,,,20,OPD,
13258,05-06-2023,BORTIANOR-APLAKU,61 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, I20.9 [Angina pectoris, unspecified]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,05-06-2023,05-06-2023,,,20,OPD,
13261,05-06-2023,GBAWE DOWN,63 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,05-06-2023,05-06-2023,,,10,OPD,
13377,05-06-2023,WEIJA TETEGU ,73 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,,,,,05-06-2023,05-06-2023,,,20,OPD,
13421,05-06-2023,"TUBA , IIRGATION FARMS",54 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, K29.1 [Other acute gastritis]  ==> OLD, A02.25 [Salmonella pyelonephritis]  ==> OLD, K59.0 [Constipation]  ==> OLD",No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 30 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TDS |  For 10 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], LACTULOSE LIQUID3.1-3.7G/5ML[ LACTULOSE | 300ML | Syrup | TID |  For 10 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], LACTULOSE LIQUID3.1-3.7G/5ML[ LACTULOSE | 300ML | Syrup ]",,,05-06-2023,05-06-2023,,,20,OPD,
13430,05-06-2023,"GBAWE , TELECOM",70 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, R00.0 [Tachycardia, unspecified]  ==> OLD, F06.4 [Organic anxiety disorder]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], AMITRIPTYLINE TABLET 50MG[ AMITRIPTYLINE | 50MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], WARFARIN 5MG[  |  |  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], AMITRIPTYLINE TABLET 50MG[ AMITRIPTYLINE | 50MG | Tablet ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ]",,,05-06-2023,05-06-2023,,,20,OPD,
13448,05-06-2023,"GBAWE, TELECOM",65 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,E08.08 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 100MG[ LOSARTAN | 100MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ]","ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], LOSARTAN TABLET 100MG[ LOSARTAN | 100MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ]",,,05-06-2023,05-06-2023,,,0,OPD,
13456,05-06-2023,bubiashie,57 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,E08.9 [Diabetes mellitus due to underlying condition without complications]  ==> OLD,,No,Insured,,,,,05-06-2023,05-06-2023,,,10,OPD,
13475,05-06-2023,awoshie A LANE,57 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> NEW,,No,Non-Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ]",,,05-06-2023,05-06-2023,,,70,OPD,
13526,05-06-2023,kasoa,54 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 90 Days  ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE TABLET 20MG (SLOW RELEASE)[ NIFEDIPINE | 20MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,05-06-2023,05-06-2023,,,20,OPD,
13625,05-06-2023,"KASOA,ANNOR TOWN",61 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 30 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 30 Days  ]","GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ]",TRADER,,05-06-2023,05-06-2023,,,25,OPD,
13643,05-06-2023,MANHEAN,66 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, A02.25 [Salmonella pyelonephritis]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 30 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 30 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 30 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], ALKA 5  SYRUP[ ALKA 5  | 100ML | Syrup | BID |  For 10 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], ALKA 5  SYRUP[ ALKA 5  | 100ML | Syrup ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,05-06-2023,05-06-2023,,,20,OPD,
13661,05-06-2023,WEIJA-CHOICE,59 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ]",TRADER,,05-06-2023,05-06-2023,,,10,OPD,30374/17 MR-1A-F4-33
13712,05-06-2023,anyaa,39 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD,No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 30 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ]",,,05-06-2023,05-06-2023,,,10,OPD,
14146,03-06-2023,"MALLAM
KOKROKO",25 Year(s),Male,ACCIDENT & EMERGENCY,Detention for Observation Adult,,No Outcome,NA ,E13.1 [Other specified diabetes mellitus: With ketoacidosis]  ==> NEW,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], METRONIDAZOLE INJECTION 5MG/ML IN 100ML[ METRONIDAOLE | 500MG IN100ML | Infusion | Stat |  For 2 Days  ], CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion | Stat |  For 2 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], METRONIDAZOLE INJECTION 5MG/ML IN 100ML[ METRONIDAOLE | 500MG IN100ML | Infusion ], CIPROFLOXACIN INFUSION 200MG[ CIPROFLOXACIN | 2MG/ML IN 100ML | Infusion ]",FOOD VENDER,,03-06-2023,03-06-2023,,,140,OPD,
14166,02-06-2023,AMANFRO ,65 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.9 [Type 2 diabetes mellitus without complications]  ==> OLD,"J06.9 [Acute upper respiratory infection, unspecified]  ==> NEW, K29.7 [Gastritis, unspecified]  ==> NEW, I10.00 [Essential (primary) hypertension]  ==> OLD",No,Insured,"OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | BDS |  For 7 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TDS |  For 7 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BDS |  For 5 Days  ], CARBOCISTEINE SYRUP[ CARBOCISTEINE -ADULT | 5% 250MG/5ML | Syrup | TDS |  For 7 Days  ]","OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ], CARBOCISTEINE SYRUP[ CARBOCISTEINE -ADULT | 5% 250MG/5ML | Syrup ]",,,02-06-2023,02-06-2023,,,20,OPD,
14219,02-06-2023,kasoa off town,66 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 90 Days  ],,,,02-06-2023,02-06-2023,,,20,OPD,
14258,02-06-2023,GBAWE CP,73 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, K29.1 [Other acute gastritis]  ==> OLD, A01.0 [Typhoid fever]  ==> OLD, B50.9 [Plasmodium falciparum malaria, unspecified]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], ATENOLOL TABLET 50MG[ ATENOLOL | 50MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], ARTEMETHER+LUMEFANTRIN 80/480MG(LONART)[  | 80mg/480mg | Tablet | BID |  For 3 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TID |  For 10 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], WARFARIN 5MG[  |  |  | OD |  For 90 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ],  TABLET SECNIDAZOLE 1G[ SECNIDAZOLE | 1G | Tablet | OD |  For 1 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATENOLOL TABLET 50MG[ ATENOLOL | 50MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], ARTEMETHER+LUMEFANTRIN 80/480MG(LONART)[  | 80mg/480mg | Tablet ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], WARFARIN 5MG[  |  |  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ],  TABLET SECNIDAZOLE 1G[ SECNIDAZOLE | 1G | Tablet ]",,,02-06-2023,02-06-2023,,,25,OPD,
14286,02-06-2023,MALLAM ,55 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,POST SURGERY REVIEW ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"L03.1 [Cellulitis of other parts of limb]  ==> OLD, A20.7 [Septicaemic plague]  ==> OLD",No,Insured,"CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QID |  For 14 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ], WARFARIN 5MG[  |  |  | BID |  For 30 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BID |  For 5 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet | BID |  For 14 Days  ], POVIDONE+METRONIDAZOLE (DREZ) OINTMENT 30G[ DREZ OINTMENT | 30G | Ointment | BID |  For 10 Days  ]","CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], WARFARIN 5MG[  |  |  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet ], POVIDONE+METRONIDAZOLE (DREZ) OINTMENT 30G[ DREZ OINTMENT | 30G | Ointment ]",,,02-06-2023,02-06-2023,,,20,OPD,
14316,02-06-2023,apleku,62 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], WARFARIN 5MG[  |  |  | BID |  For 30 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], WARFARIN 5MG[  |  |  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ]",,,02-06-2023,02-06-2023,,,20,OPD,
14368,02-06-2023,gbawe,58 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"L03.90 [Cellulitis, unspecified]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], WARFARIN 5MG[  |  |  | BID |  For 30 Days  ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | QID |  For 14 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TDS |  For 7 Days  ], POVIDONE+METRONIDAZOLE (DREZ) OINTMENT 30G[ DREZ OINTMENT | 30G | Ointment | BID |  For 10 Days  ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet | BID |  For 14 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], WARFARIN 5MG[  |  |  ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], POVIDONE+METRONIDAZOLE (DREZ) OINTMENT 30G[ DREZ OINTMENT | 30G | Ointment ], ASCORBIC ACID TABLET 500MG[ VITAMIN C | 500MG | Tablet ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ]",,,02-06-2023,02-06-2023,,,20,OPD,
14620,02-06-2023,MACARTHEY HILL,57 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,MEDI02A [Diabetes - Simple >=12 Yrs]  ==> NEW,,No,Insured,,,,,02-06-2023,02-06-2023,,,10,OPD,
14669,02-06-2023,"ABLEKUMA
PENTECOST JNC",49 Year(s),Female,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E11.65 [Type 2 diabetes mellitus with hyperglycemia]  ==> OLD,"B33.3 [Retrovirus infections, not elsewhere classified]  ==> OLD",No,Insured,"INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection | OD |  For 1 Days  ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | OD |  For 1 Days  ]","INSULIN SOBUBLE HM100UNITS/ML[ ACTRAPID | 100IU/10ML | Injection ], SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ]",TRADER,,02-06-2023,02-06-2023,,,20,OPD,
14735,01-06-2023,ACCRA,59 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,,,civil servant,,01-06-2023,01-06-2023,,,70,OPD,
14736,01-06-2023,OMANJOR,52 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"E78.5 [Hyperlipidaemia, unspecified]  ==> OLD, A02.25 [Salmonella pyelonephritis]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,01-06-2023,01-06-2023,,,25,OPD,
14799,01-06-2023,"KASOA
NEW TOWN",71 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E13.43 [Other specified diabetes mellitus with diabetic autonomic (poly)neuropathy]  ==> NEW,,No,Insured,"SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion | Stat |  For 1 Days  ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule | Daily |  For 30 Days  ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ]","SODIUM CHLORIDE INFUSION 0.9%(500ML)[ NORMAL SALINE | 0.9% 500ML | Infusion ], PREGABALIN CAPSULES 75MG[ PREGABALIN | 75MG | Capsule ], METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ]",pension,,01-06-2023,01-06-2023,,,40,OPD,
14818,01-06-2023,TETEGU,47 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD,,No,Non-Insured,,,,,01-06-2023,01-06-2023,,,10,OPD,
14819,01-06-2023,Weija ,73 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ]",,,01-06-2023,01-06-2023,,,10,OPD,3226/17
14820,01-06-2023,SANTA MARIA,63 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,01-06-2023,01-06-2023,,,10,OPD,
14822,01-06-2023,mallam bola road ,56 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE TABLET 5MG[ AMLODIPINE | 5MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,01-06-2023,01-06-2023,,,20,OPD,
14823,01-06-2023,kasoa amanfo,49 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, K27.3 [Peptic ulcer, site unspecified: Acute without haemorrhage or perforation]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | OD |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | OD |  For 90 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TID |  For 10 Days  ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule | BID |  For 10 Days  ],  TABLET SECNIDAZOLE 1G[ SECNIDAZOLE | 1G | Tablet | OD |  For 1 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ]",,,,01-06-2023,01-06-2023,,,10,OPD,
14824,01-06-2023,kasoa,49 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], VITAMIN B COMPLEX (NAT B ) CAPSULES[ NAT B |  | Capsule ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ]",,,01-06-2023,01-06-2023,,,20,OPD,
14826,01-06-2023,KASOA KABULEY JUNCTION,66 Year(s),Male,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, M54.4 [Lumbago with sciatica]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 90 Days  ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | OD |  For 90 Days  ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LISINOPRIL TABLET 10MG[ LISINOPRIL | 10MG | Tablet ], WARFARIN 5MG[  |  |  ], DICLOFENAC SUPPOSITORY 100MG[ DICLOFENAC | 100MG | Suppository ]",,,01-06-2023,01-06-2023,,,20,OPD,
14828,01-06-2023,ablekuman ,79 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.10 [Diabetes mellitus due to underlying condition with ketoacidosis without coma]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, A02.25 [Salmonella pyelonephritis]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 30 Days  ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet | OD |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 30 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BDS |  For 14 Days  ],  TABLET SECNIDAZOLE 1G[ SECNIDAZOLE | 1G | Tablet | OD |  For 1 Days  ], ALKA 5  SYRUP[ ALKA 5  | 100ML | Syrup | TDS |  For 1 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], AMLODIPINE TABLET 10MG[ AMLODIPINE | 10MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ],  TABLET SECNIDAZOLE 1G[ SECNIDAZOLE | 1G | Tablet ], ALKA 5  SYRUP[ ALKA 5  | 100ML | Syrup ]",,,01-06-2023,01-06-2023,,,20,OPD,
14830,01-06-2023,BORTIANOR,69 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | BID |  For 90 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], WARFARIN 5MG[  |  |  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,01-06-2023,01-06-2023,,,20,OPD,
14841,01-06-2023,new bortianor,20 Year(s),Female,DIETERAPY,General Consultation Adult,,No Outcome,NA ,MEDI02A [Diabetes - Simple >=12 Yrs]  ==> OLD,,No,Insured,,,,,01-06-2023,01-06-2023,,,10,OPD,
14845,01-06-2023,ABOSSEY OKAI,64 Year(s),Female,SURGICAL OPD,Surgical Review Consultation ,,No Outcome,NA ,E11.621 [Type 2 diabetes mellitus with foot ulcer]  ==> OLD,,No,Insured,,,,,01-06-2023,01-06-2023,,,40,OPD,
14846,01-06-2023,"kasoa 
iron city",68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], WARFARIN 5MG[  |  |  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ]",,,01-06-2023,01-06-2023,,,20,OPD,
14850,01-06-2023,"ABLEKUMA , AGAPE",51 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,01-06-2023,01-06-2023,,,10,OPD,
14852,01-06-2023,"Odorkor
",72 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD, B35.4 [Tinea corporis]  ==> OLD, B82.0 [Intestinal helminthiasis, unspecified]  ==> OLD, E78.5 [Hyperlipidaemia, unspecified]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | OD |  For 90 Days  ], ATORVASTATIN TABLET 20MG[ ATORVASTATIN | 20MG | Tablet | OD |  For 90 Days  ], GRISEOFULVIN TABLET 500MG[ GRISEOVULFIN | 500MG | Tablet | BID |  For 14 Days  ], ALBENDAZOLE TABLET 400MG[ ALBENDAZOLE | 400MG | Tablet | OD |  For 1 Days  ], BETAMETHASONE DIPROPIONATE[ DIPROSON  | 0.05% 30G | Cream | BID |  For 10 Days  ], FEXOFENADINE TABLET 120MG (ZYFEN)[ ZYFEN | 120MG | Tablet | OD |  For 10 Days  ]",,pension,,01-06-2023,01-06-2023,,,20,OPD,
14874,01-06-2023,ODORKOR ,58 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 90 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ]",,,01-06-2023,01-06-2023,,,70,OPD,
14877,01-06-2023,kawsibu,72 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, W35.00 [Explosion and rupture of boiler]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD",No,Insured,"INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | OD |  For 90 Days  ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule | BID |  For 14 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 7 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 90 Days  ]","INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], WARFARIN 5MG[  |  |  ], CLINDAMYCIN CAPSULE 300MG[ CLINDAMYCIN | 300MG | Capsule ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ]",,,01-06-2023,01-06-2023,,,10,OPD,
14881,01-06-2023,kasoa,63 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, F06.4 [Organic anxiety disorder]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 30 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | BID |  For 30 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 30 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | OD |  For 30 Days  ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet | BID |  For 30 Days  ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet | Nocte |  For 30 Days  ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet | Nocte |  For 5 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], METHYLDOPA TABLET 250MG[ METHYLDOPA | 250MG | Tablet ], AMITRIPTYLINE TABLET 25MG[ AMITRIPTYLINE | 25MG | Tablet ], DIAZEPAM TABLET 10MG[ VALIUM | 10MG | Tablet ]",,,01-06-2023,01-06-2023,,,20,OPD,
14917,01-06-2023,new gbawe,68 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, A02.25 [Salmonella pyelonephritis]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD, K29.1 [Other acute gastritis]  ==> OLD",No,Non-Insured,"WARFARIN 5MG[  |  |  | BID |  For 90 Days  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule | OD |  For 90 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TID |  For 10 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ],  TABLET SECNIDAZOLE 1G[ SECNIDAZOLE | 1G | Tablet | OD |  For 1 Days  ], ALKA 5  SYRUP[ ALKA 5  | 100ML | Syrup | TID |  For 10 Days  ]","WARFARIN 5MG[  |  |  ], Methylcobalamin+Alpha Lapoic Acid+Inositol-RENURON[ RENURON |  | Capsule ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ],  TABLET SECNIDAZOLE 1G[ SECNIDAZOLE | 1G | Tablet ], ALKA 5  SYRUP[ ALKA 5  | 100ML | Syrup ]",,,01-06-2023,01-06-2023,,,70,OPD,
14923,01-06-2023,KASOA-ADADE,83 Year(s),Female,DIABETIC CLINIC,Diabetic Review Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,"I10.00 [Essential (primary) hypertension]  ==> OLD, M16.10 [Unilateral primary osteoarthritis, unspecified hip]  ==> OLD, Z86.718 [Personal history of other venous thrombosis and embolism]  ==> OLD, K59.0 [Constipation]  ==> OLD",No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], WARFARIN 5MG[  |  |  | BID |  For 90 Days  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule | OD |  For 14 Days  ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension | TID |  For 10 Days  ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet | BID |  For 14 Days  ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel | BID |  For 5 Days  ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet | TID |  For 0 Days  ], LACTULOSE LIQUID3.1-3.7G/5ML[ LACTULOSE | 300ML | Syrup | TID |  For 0 Days  ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet | Daily |  For 0 Days  ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet | BDS |  For 0 Days  ], ALKA 5  SYRUP[ ALKA 5  | 100ML | Syrup | TDS |  For 0 Days  ], CLARITHROMYCIN CAPSULE 500MG","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], WARFARIN 5MG[  |  |  ], OMEPRAZOLE TABLET 20MG[ OMEPRAZOLE | 20MG | Capsule ], ALGINIC+MAGNESIUM HYDROXIDE+ ALUMINIUM HYDROXIDE+MAGNESIUM TRISILICATE+DIMETHICONE+OXETACAINE  SUSPE[ NUGEL - O  | 200ML | Suspension ], CIPROFLOXACIN TABLET 500MG[ CIPROFLOXACIN | 500MG | Tablet ], DICLOFENAC GEL[ DICLOFENAC GEL | 30G | Gel ], METRONIDAZOLE TABLET 400MG[ METRONIDAZOLE | 400MG | Tablet ], LACTULOSE LIQUID3.1-3.7G/5ML[ LACTULOSE | 300ML | Syrup ], ACETYLSALICYLIC ACID  TABLET 75MG(ASPIRIN)[ ASPIRIN | 75MG | Tablet ], TRAMADOL+PARACETAMOL(DORETA) TABLET[ DORETA | (37.5+325)MG | Tablet ], ALKA 5  SYRUP[ ALKA 5  | 100ML | Syrup ], CLARITHROMYCIN CAPSULE 500MG[ CLARITHROMYCIN | 500MG | Capsule ]",,,01-06-2023,01-06-2023,,,20,OPD,
14968,01-06-2023,dansoman Ebeneezer down,42 Year(s),Female,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BID |  For 90 Days  ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet | BID |  For 90 Days  ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet | OD |  For 90 Days  ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet | OD |  For 90 Days  ], FEMOM (FERROUS ASCORBATE+FOLIC ACID) SYRUP (30MG/500MCG)[  |  |  | OD |  For 90 Days  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection | BID |  For 90 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | OD |  For 90 Days  ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet | OD |  For 90 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], GLIBENCLAMIDE TABLET 5MG[ GLIBENCLAMIDE | 5MG | Tablet ], PIOGLITAZONE TABLET 30MG[ PIOGLITAZONE | 30MG | Tablet ], CLOPIDOGREL 75MG[ CLOPIDOGREL | 75MG | Tablet ], FEMOM (FERROUS ASCORBATE+FOLIC ACID) SYRUP (30MG/500MCG)[  |  |  ], INSULIN PREMIXED(30/70) HM INJECTION[ MIXTARD | 100IU/10ML | Injection ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ], LOSARTAN TABLET 50MG[ LOSARTAN | 50MG | Tablet ]",,,01-06-2023,01-06-2023,,,20,OPD,
15086,01-06-2023,"CHOICE 
SCC",80 Year(s),Male,DIABETIC CLINIC,Diabetic Consultation,,No Outcome,NA ,E08.0 [Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)]  ==> OLD,I10.00 [Essential (primary) hypertension]  ==> OLD,No,Insured,,,,,01-06-2023,01-06-2023,,,60,OPD,
15159,01-06-2023,"KASOA GALELIA,ATAA MAAME BUSTOP",67 Year(s),Female,SURGICAL OPD,Surgical Consultation ,,No Outcome,NA ,E08.65 [Diabetes mellitus due to underlying condition with hyperglycemia]  ==> OLD,"J18.0 [Bronchopneumonia, unspecified]  ==> NEW",No,Insured,"ENOXAPARIN SODIUM (CLEXANE) INJECTION 40MG[ CLEXANE | 40MG/0.4ML | Injection | Daily |  For 2 Days  ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection | OD |  For 1 Days  ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion | TDS |  For 1 Days  ]","ENOXAPARIN SODIUM (CLEXANE) INJECTION 40MG[ CLEXANE | 40MG/0.4ML | Injection ], CEFTRIAXONE INJECTION 1G[ CEFTRIAXONE | 1G | Injection ], PARACETAMOL INFUSION 1G[ PARACETAMOL | 1G | Infusion ]",TRADER,,01-06-2023,01-06-2023,,,20,OPD,
15172,01-06-2023,SCC,71 Year(s),Male,GENERAL OPD,General Consultation Adult ,,No Outcome,NA ,E08.8 [Diabetes mellitus due to underlying condition with unspecified complications]  ==> OLD,,No,Insured,METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ],METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ],,,01-06-2023,01-06-2023,,,10,OPD,
15190,01-06-2023,MCCARTHY JUNCTION,59 Year(s),Female,DM Med Refill,Refill Prescription ,,No Outcome,NA ,"E11.40 [Type 2 diabetes mellitus with diabetic neuropathy, unspecified]  ==> OLD",I10. [Essential (primary) hypertension]  ==> OLD,No,Insured,"METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet | BDS |  For 30 Days  ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet | Daily |  For 30 Days  ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet | Daily |  For 30 Days  ]","METFORMIN TABLET 500MG[ DIAMET | 500MG | Tablet ], ATENOLOL TABLET 100MG[ ATENOLOL | 100MG | Tablet ], NIFEDIPINE XL TABLET 30MG[ NIFECARD XL | 30MG | Tablet ]",,,01-06-2023,01-06-2023,,,0,OPD,30308/17  MR-1B-A6-8
